<SEC-DOCUMENT>0001437749-24-030393.txt : 20241002
<SEC-HEADER>0001437749-24-030393.hdr.sgml : 20241002
<ACCEPTANCE-DATETIME>20241002064530
ACCESSION NUMBER:		0001437749-24-030393
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20241001
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241002
DATE AS OF CHANGE:		20241002

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Comstock Inc.
		CENTRAL INDEX KEY:			0001120970
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL ORGANIC CHEMICALS [2860]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				650955118
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35200
		FILM NUMBER:		241345199

	BUSINESS ADDRESS:	
		STREET 1:		117 AMERICAN FLAT ROAD
		STREET 2:		PO BOX 1118
		CITY:			VIRGINIA CITY,
		STATE:			NV
		ZIP:			89440
		BUSINESS PHONE:		775-847-5272

	MAIL ADDRESS:	
		STREET 1:		117 AMERICAN FLAT ROAD
		STREET 2:		PO BOX 1118
		CITY:			VIRGINIA CITY,
		STATE:			NV
		ZIP:			89440

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Comstock Mining Inc.
		DATE OF NAME CHANGE:	20100720

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GOLDSPRING INC
		DATE OF NAME CHANGE:	20040730

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GOLDSPRING
		DATE OF NAME CHANGE:	20030821
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>lode20241001_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:lode="http://www.lode.com/20241001"><head>
	<title>lode20241001_8k.htm</title>
	<!-- Generated by ThunderDome Portal - 10/2/2024 12:00:04 AM -->
<meta http-equiv="Content-Type" content="text/html"/></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20248K" name="dei:AmendmentFlag" id="ixv-240">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20248K" name="dei:EntityCentralIndexKey" id="ixv-241">0001120970</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="lode-20241001.xsd" xlink:type="simple"/>
</ix:references>
<ix:resources>
<xbrli:context id="d20248K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001120970</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-10-01</xbrli:startDate>
<xbrli:endDate>2024-10-01</xbrli:endDate>
</xbrli:period>
</xbrli:context>



</ix:resources>
</ix:header>
</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNITED STATES</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Washington, D.C. 20549</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM <ix:nonNumeric contextRef="d20248K" name="dei:DocumentType" id="ixv-16"><b>8-K</b></ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CURRENT REPORT</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="d20248K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="ixv-251">October 1, 2024</ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:18pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityRegistrantName" id="ixv-27"><b>COMSTOCK INC.</b></ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Exact Name of Registrant as Specified in its Charter)</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-36"><b>Nevada</b></ix:nonNumeric></div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">(State or Other</div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">Jurisdiction of Incorporation)</div>
			</td>
			<td style="vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityFileNumber" id="ixv-42"><b>001-35200</b></ix:nonNumeric></div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">(Commission File Number)</div>
			</td>
			<td style="vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityTaxIdentificationNumber" id="ixv-47"><b>65-0955118</b></ix:nonNumeric></div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">(I.R.S. Employer</div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">Identification Number)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressAddressLine1" id="ixv-54"><b>117 American Flat Road</b></ix:nonNumeric>, <ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressCityOrTown" id="ixv-56"><b>Virginia City</b></ix:nonNumeric>, <ix:nonNumeric contextRef="d20248K" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="ixv-58"><b>Nevada</b></ix:nonNumeric> <ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressPostalZipCode" id="ixv-60"><b>89440</b></ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Address of Principal Executive Offices, including Zip Code)</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Registrant&#8217;s Telephone Number, including Area Code:&#160;<b>(<ix:nonNumeric contextRef="d20248K" name="dei:CityAreaCode" id="ixv-65"><b>775</b></ix:nonNumeric>) <ix:nonNumeric contextRef="d20248K" name="dei:LocalPhoneNumber" id="ixv-67"><b>847-5272</b></ix:nonNumeric></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Not Applicable</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Former Name or Former Address, if Changed Since Last Report)</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 18pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 18pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="ixv-252">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="ixv-253">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="ixv-254">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="ixv-255">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: bottom; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">Title of each class</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">Trading symbol(s)</div>
			</td>
			<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: bottom; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">Name of each exchange on which registered</div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-left: 1px solid black; border-right: 1px solid black;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20248K" name="dei:Security12bTitle" id="ixv-256">Common Stock</ix:nonNumeric>, par value $0.000666 per share</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20248K" name="dei:TradingSymbol" id="ixv-257">LODE</ix:nonNumeric></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-left: 1px solid black; border-right: 1px solid black;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-258">NYSE</ix:nonNumeric> AMERICAN</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (</b>&#167;<b>230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (</b>&#167;<b>240.12b-2 of this chapter).</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Emerging growth company</b>&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="ixv-259">&#9744;</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#9744;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 1.01 Entry into a Material Definitive Agreement.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On October 1, 2024, Comstock IP Holdings LLC, a subsidiary of Comstock Inc. (the &#8220;Company&#8221;), executed an Exclusive License Agreement (&#8220;ELA&#8221;) and a Cooperative Research and Development Agreement (&#8220;CRADA&#8221;) with Alliance for Sustainable Energy LLC (&#8220;Alliance&#8221;), the managing and operating contractor of the U.S. Department of Energy&#8217;s (&#8220;DOE&#8221;) National Renewable Energy Laboratory (&#8220;NREL&#8221;), involving technologies developed by NREL and the Massachusetts Institute of Technology (&#8220;MIT&#8221;) for conversion of lignocellulosic biomass into aromatic sustainable aviation fuel (&#8220;SAF&#8221;). NREL and MIT are separately party to an Inter-Institutional Agreement that appointed NREL the exclusive right to license NREL&#8217;s and MIT&#8217;s joint intellectual properties. Comstock IP Holdings previously granted Comstock Fuels Corporation the master exclusive rights for commercialization of its existing and new renewable fuels technologies.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The ELA provides Comstock IP Holdings with the exclusive worldwide right to use the NREL technologies in the processing and conversion of seed plants to renewable fuels and renewable fuel feedstocks, including native, hybrid, and transgenic phenotypes, and derivatives thereof, excluding switchgrass, big bluestem, miscanthus, and the leaves, stalks, and husks produced during the harvesting of corn, subject to limited geographic restrictions, in exchange for royalty and other fees linked to sales of licensed products and sublicensing.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The terms of the CRADA involve a three-year scope of work to jointly develop an integrated process based on Comstock&#8217;s existing process and the NREL technologies for the solvocatalytic refining of woody biomass into aromatic SAF and other renewable fuels. Comstock will fund the research and contribute staff, equipment, and use of its pilot facility in Wisconsin. The joint work will be supported by NREL, MIT, and Washington State University.&#160;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The foregoing description of the License Agreement is qualified in its entirety by reference to the full text of the License Agreement, a copy of which is filed as Exhibit&#160;10.1, to this Current Report on Form 8-K and incorporated herein by reference. A copy of the press release is attached as Exhibit 99.1 to this Form 8-K.</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 9.01 Financial Statements and Exhibits.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(d)&#160;<i>Exhibits</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">10.1</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><a href="ex_728952.htm" style="-sec-extract:exhibit;">License Agreement (portions of the exhibit have been omitted)</a></div>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">99.1</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><a href="ex_729047.htm" style="-sec-extract:exhibit;">Press release</a></div>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">104</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SIGNATURE</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td colspan="3" style="vertical-align:middle;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</div>
			</td>
		</tr>

</tbody></table>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: bottom; width: 55%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>COMSTOCK INC.</b></div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: bottom; width: 55%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: bottom; width: 55%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 55%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Date: October 2, 2024</div>
			</td>
			<td style="vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">By:</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 35%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">/s/ Corrado De Gasperis</div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: bottom; width: 55%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: bottom; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 35%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Corrado De Gasperis</div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Executive Chairman and Chief Executive</div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Officer</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex_728952.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html><head>
	<title>ex_728952.htm</title>

	<!-- Generated by ThunderDome Portal - 10/2/2024 2:05:19 AM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><b><u>Exhibit 10.1</u></b></p>

<div contenteditable="false" data-hf-endpoint="start" data-hf-html="%3Cdiv%20style%3D%22width%3A%20100%25%3B%22%3E%3Cdiv%20class%3D%22hf-row%22%3E%3Cdiv%20class%3D%22hf-cell%22%20style%3D%22font-family%3A%20%26quot%3BTimes%20New%20Roman%26quot%3B%2C%20Times%2C%20serif%3B%20font-size%3A%2010pt%3B%20text-align%3A%20right%3B%20margin%3A%200pt%3B%20width%3A%2099.9%25%3B%20display%3A%20inline-block%3B%22%3ENREL%20License%20Agreement%20No.%2024-00500%3C%2Fdiv%3E%3C%2Fdiv%3E%3Cdiv%20class%3D%22hf-row%22%3E%3Cdiv%20class%3D%22hf-cell%20TOCLink%22%20style%3D%22text-align%3A%20left%3B%20margin%3A%200pt%3B%20width%3A%2099.9%25%3B%20display%3A%20inline-block%3B%22%3E%3C%2Fdiv%3E%3C%2Fdiv%3E%3C%2Fdiv%3E" data-hf-type="header">&nbsp;</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">NREL License Agreement No. 24-00500</p>

<div contenteditable="false" data-applyto="p" data-auto-pgnum="start" data-displaynum="1" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="Page " data-startnum="1" data-suffix="" data-textalign="right">&nbsp;</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><u>Certain identified information has been excluded from the exhibit because it is both not material and would be competitively harmful if publicly disclosed.</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><u>EXCLUSIVE LICENSE AGREEMENT</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">This <b>EXCLUSIVE LICENSE AGREEMENT </b>(hereinafter &#8220;<b><u>Agreement</u></b>&#8221;), which shall be effective on <b>OCTOBER 1, 2024 </b>(the &#8220;<b><u>Effective Date</u></b>&#8221;) below, is between <b>ALLIANCE FOR SUSTAINABLE ENERGY, LLC </b>(hereinafter "<b><u>Alliance</u></b>"), Management and Operating Contractor for the <b>NATIONAL RENEWABLE ENERGY LABORATORY </b>(hereinafter &#8220;<b><u>NREL</u></b>&#8221;) located at 15013 Denver West Parkway, Golden, Colorado 80401 and <b>COMSTOCK IP HOLDINGS LLC</b>, a for-profit company organized and existing under the laws of the State of Nevada and having a principal place of business at 117 American Flat Road, Virginia City, Nevada 89440 (hereinafter "<b><u>Licensee</u></b>" and, together with Alliance, sometimes referred to individually herein as a &#8220;<b><u>Party</u></b>&#8221; and, collectively, as the &#8220;<b><u>Parties</u></b>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>WHEREAS </b>Alliance manages and operates NREL under authority of its Prime Contract No. DE-AC36-08GO28308 (hereinafter "<b><u>Prime Contract</u></b>") with the United States Government as represented by the Department of Energy (hereinafter "<b><u>DOE</u></b>").</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>WHEREAS </b>Researchers at NREL and the Massachusetts Institute of Technology (&#8220;<b><u>MIT</u></b>&#8221;), as part of their employment at their respective employers, have developed certain inventions pertaining to the reductive catalytic fractionation and <i>in situ </i>hydrotreatment of biomass to fuel range feedstocks and fuels (&#8220;<b><u>Inventions</u></b>&#8221;), which were conceived or first reduced to practice at least in part in the performance of work at NREL under the above Prime Contract, and which have culminated in the Licensed Patent Rights described in <b><u>Exhibit A</u></b><b> </b>attached hereto and incorporated herein by reference.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>WHEREAS</b>, pursuant to the terms of the Prime Contract and existing laws of the United States, Alliance acquired rights in and to all now and hereafter existing Licensed Patent Rights covering the Inventions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>WHEREAS </b>Licensee is in the business of developing, commercializing, and licensing technologies, including, without limitation, the solvolysis, fractionation, and other processes to convert lignocellulosic biomass, in pertinent part, into (i) a mixture of solvents (&#8220;<b><u>Solvent Mix</u></b>&#8221;) and derivatives of hemicellulose and lignin (together with the Solvent Mix, the &#8220;<b><u>Organic Phase</u></b>&#8221;), from which the Solvent Mix is removed to produce a concentrated mixture of hydrophobic hydrocarbons derived from hemicellulose and lignin (&#8220;<b><u>Concentrated Organic Phase</u></b>&#8221;) for use in producing renewable fuels and precursors for renewable fuels (&#8220;<b><u>Comstock Background IP</u></b>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>WHEREAS </b>Licensee desires to use the Inventions and Licensed Patent Rights for the further processing of the Organic Phase and/or Concentrated Organic Phase to produce reductive catalytic fractionation oil (&#8220;<b><u>RCF Oil</u></b>&#8221;) and/or hydrodeoxygenated oil (&#8220;<b><u>HDO</u></b>&#8221;) for use in producing sustainable aviation fuel (&#8220;<b><u>SAF</u></b>&#8221;) and/or other renewable fuels (together with SAF, &#8220;<b><u>ASTM Specification Fuels</u></b>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>WHEREAS </b>Licensee and Alliance have entered into that certain funded Cooperative Research and Development Agreement of even date herewith (&#8220;<b><u>CRADA</u></b>&#8221;) to jointly develop and validate an integrated process based on the Inventions, Licensed Patent Rights, and Comstock Background IP for the solvocatalytic refining of lignocellulosic biomass into RCF Oil, HDO, and ASTM Specification Fuels, including, <i>inter alia</i>, use of the Licensed Patent Rights to (i) produce HDO from the Organic Phase with an HDO recycle loop at TRL 3 (&#8220;<b><u>CRADA Task 1.1</u></b>&#8221;); (ii) produce ASTM Specification Fuels from the HDO produced in Task 1.1 at TRL 3 (&#8220;<b><u>CRADA Task 1.2</u></b>&#8221;); (iii) optimize and scale the process validated in Task 1.1 and 1.2 to produce HDO and ASTM Specification Fuel at TRL 6 to support commercialization (&#8220;<b><u>CRADA Task 1.3</u></b>&#8221;); (iv) demonstration of alternative application of the Licensed Patent Rights in which RCF Oil is produced during Licensee&#8217;s existing feedstock solvolysis and fractionation process with hydrogen produced <i>in situ </i>by aqueous phase reformation of water (&#8220;<b><u>RCF Digestion</u></b>&#8221;) at TRL 3 at Licensee&#8217;s Wisconsin facility (&#8220;<b><u>CRADA Milestone 2.0</u></b>&#8221;); (v) demonstration of RCF Digestion and HDO production with an HDO recycle loop at <sup style="vertical-align:top;line-height:120%;">TRL 3 at NREL (</sup>&#8220;<b><u><sup style="vertical-align:top;line-height:120%;">CRADA Milestone 2.1</sup></u></b>&#8221;<sup style="vertical-align:top;line-height:120%;">); (v) validation of Pt/NiAl</sup>2<sup style="vertical-align:top;line-height:120%;">O</sup>4 <sup style="vertical-align:top;line-height:120%;">activity and stability for use in RCF </sup>Digestion (&#8220;<b><u>CRADA Milestone 2.2</u></b>&#8221;); (vi) demonstration of an integrated process based on the Inventions, Licensed Patent Rights, and Comstock Background IP (&#8220;<b><u>Solvocatalytic Refining</u></b>&#8221; or &#8220;<b><u>SR</u></b>&#8221;) involving RCF Digestion, pulp removal, solvent separation, hydrodeoxygenation, additional hydroprocessing (if required), and distillation to produce HDO at TRL 3 (&#8220;<b><u>CRADA Milestone 2.3</u></b>&#8221;); (vii) produce ASTM Specification Fuels from the HDO produced in Task 2.3 at TRL 3 (&#8220;<b><u>CRADA Task 2.4</u></b>&#8221;); and (viii), if SR is validated at TRL 3, iterating SR to successively higher states of technology readiness based on the go-no-go and other conditions stated in the CRADA, culminating in demonstration of SR at TRL 6 to support commercialization (&#8220;<b><u>CRADA Milestone 2.5</u></b>&#8221;) .</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="1" data-prefix="Page " data-suffix="" style="text-align: right; font-size: 10pt; font-family: Times New Roman;">Page 1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="width: 100%;">
<div class="hf-row">
<div class="hf-cell" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; margin: 0pt; width: 99.9%; display: inline-block;">NREL License Agreement No. 24-00500</div>
</div>

<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: left; margin: 0pt; width: 99.9%; display: inline-block;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>WHEREAS </b>Licensee desires to obtain an exclusive license to the Licensed Patent Rights on the terms hereinafter set forth, and Alliance is willing to grant such rights so that the Inventions and Licensed Patent Rights will be developed and used to the fullest extent possible for the benefit of the general public.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>NOW, THEREFORE</b>, for and in consideration of the foregoing as well as the faithful performance by each Party hereto of the obligations and covenants herein contained on their part to be performed, the Parties hereto agree as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Definitions</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Affiliate</u></b>&#8221;&nbsp;of a Party means any person or entity that, at any time during the term of this Agreement, directly or indirectly controls, is controlled by, or is under common control with such Party, where &#8220;<b><u>control</u></b>&#8221;&nbsp;means ownership of fifty percent (50%) or more of the voting power of the outstanding voting securities (but only as long as such person or entity meets these requirements). Affiliates shall exclude any Prohibited Entity.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Change in Control</u></b>&#8221;&nbsp;means a change, directly or indirectly, of the power to direct the management or policies of Licensee whether such power is exercised through one or more intermediary companies or pursuant to an agreement, written or oral, and whether such power is established through ownership or voting of securities, or common directors, officers, or stockholders, or voting trusts, holding trusts, or debt holdings, or contract, or any other direct or indirect means. It is assumed that control exists from the ownership or the power to vote, directly or indirectly, 25% or more of the voting securities of such entity.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.3.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Combination Product(s)</u></b>&#8221;&nbsp;means any material, composition, or other product or service, the manufacture, use, import, offer to sell or sale of which would constitute, but for the license granted to Licensee herein, an infringement of a claim of the Licensed Patent Rights (infringement shall include, but is not limited to, direct, contributory, or inducement to infringe), along with one or more compatible products produced and/or sold together in a single integrated offering resulting in receipt of Net Sales or Sublicensing Revenue by Licensee.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.4.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Combination Product Percentage</u></b>&#8221;&nbsp;means the cost to produce the applicable Licensed Product, divided by the total cost to produce the Combination Product; provided, however, that in no event shall the Combination Product Percentage be less than fifty percent (50%).</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.5.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Commercialization Milestones</u></b>&#8221;&nbsp;shall have that meaning set forth in <b><u>Exhibit C</u></b>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.6.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Comstock Background IP</u></b>&#8221;&nbsp;shall have that meaning set forth in the preamble of this Agreement, as described more fully in the CRADA.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.7.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Control</u></b>&#8221;&nbsp;and &#8220;<b><u>Controlled</u></b>&#8221;&nbsp;means the power to direct the management of an entity through having twenty five percent (25%) or more of board membership, ownership of twenty five percent (25%) or more of the voting power of the outstanding voting securities (but only as long as such person or entity meets these requirements).</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.8.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>DOE Country of Risk</u></b>&#8221;&nbsp;means those countries defined, at the time of the relevant transaction or consideration, by DOE as Foreign Countries of Risk. At the time of execution of this License Agreement, the DOE Countries of Risk are Russia, China, Iran, and North Korea.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.9.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Exclusive</u></b>&#8221;&nbsp;means a grant of rights to Licensee where Licensee is the only entity that may commercially practice the Licensed Patent Rights in the Exclusive Field of Use and Geography, subject to the Government&#8217;s nonexclusive, nontransferable, irrevocable, paid-up license to practice or have practiced for or on behalf of the Government the licensed intellectual property throughout the world.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.10.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Field of Use</u></b>&#8221;&nbsp;means processing and conversion of seed plants to renewable fuels and renewable fuel feedstocks, including native, hybrid, and transgenic phenotypes, and derivatives thereof, excluding switchgrass (genus <i>Panicum</i>), big bluestem (genus <i>Andropogon</i>), miscanthus (genus <i>Miscanthus</i>), and the leaves, stalks, and husks produced during the harvesting of corn (genus <i>Zea</i>).</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="Page " data-suffix="" style="text-align: right; font-size: 10pt; font-family: Times New Roman;">Page 2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="width: 100%;">
<div class="hf-row">
<div class="hf-cell" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; margin: 0pt; width: 99.9%; display: inline-block;">NREL License Agreement No. 24-00500</div>
</div>

<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: left; margin: 0pt; width: 99.9%; display: inline-block;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.11.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Foreign Entity</u></b>&#8221;&nbsp;means an entity that has its corporate headquarters outside of the United States, or an entity that is organized under the laws of a government other than one of the states or territories of the United States, or a person that is not either a United States citizen or a lawful permanent resident of the United States.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.12.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Government</u></b>&#8221;&nbsp;shall mean the federal government of the United States of America.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.13.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Influence</u></b>&#8221;&nbsp;and &#8220;<b><u>Influenced</u></b>&#8221;&nbsp;mean the power to substantially influence the management of an entity through having twenty five percent (25%) or more of board membership, or ownership of twenty five percent (25%) or more of the voting power of the outstanding voting securities (but only as long as such person or entity meets the requirements).</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.14.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>License Fees</u></b>&#8221;&nbsp;means the Up-Front Fees, Royalty Fees, and Minimum Annual Royalty Fees set forth in <b><u>Exhibit B</u></b>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.15.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Licensed Patent Rights</u></b>&#8221;&nbsp;shall have that meaning set forth in <b><u>Exhibit A</u></b>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.16.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Licensed Product(s)</u></b>&#8221;&nbsp;means any material, composition, or other product or service, the manufacture, use, import, offer to sell or sale of which would constitute, but for the license granted to Licensee herein, an infringement of a claim of the Licensed Patent Rights (infringement shall include, but is not limited to, direct, contributory, or inducement to infringe).</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.17.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Net Sales</u></b>&#8221; means the gross sales received by Licensee from the production and sale of Licensed Products during a particular accounting period. Net Sales excludes the following items, but only as they pertain to the making, using, selling, or importing of Licensed Products: actual costs Licensee or its Sublicensees incurred due to returns of Licensed Products, freight, and import, export, excise, or sales taxes (excluding income taxes), costs of transportation insurance incurred in the sales of Licensed Products. When Licensed Products are used or transferred, but not sold by Licensee, Net Sales shall mean the fair market value of the Licensed Products as if they were sold to an unrelated third party in similar quantities.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.18.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Non-Exclusive</u></b>&#8221;&nbsp;means a grant of rights to Licensee where Alliance is free to license the Licensed Patent Rights to others as it deems appropriate.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.19.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Patenting Costs</u></b>&#8221;&nbsp;means any past or ongoing costs incurred or to be incurred, including but not limited to government fees and attorneys&#8217;&nbsp;or other legal personnel fees, in the course of preparing, filing, prosecuting and maintaining any of the Licensed Patent Rights, including continuations, re- examinations, reissues, appeals, <i>inter partes </i>reviews, post-grant reviews, covered business method reviews, and supplemental examinations.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.20.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Permitted Entity</u></b>&#8221;&nbsp;means any third party person or entity that is not a Prohibited Entity and that is not Controlled or Influenced by any Prohibited Entity.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.21.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Prohibited Entity</u></b>&#8221;&nbsp;means (1) any entity located, organized, or headquartered in a DOE Country of Risk; (2) a Foreign Entity of a DOE Country of Risk; (3) a Subsidiary (at any level) of a Foreign Entity of a DOE Country of Risk; (4) any entity Controlled or Influenced by a Foreign Entity of a DOE Country of Risk; (5) any entity sanctioned or violating sanctions imposed by OFAC; (6) any entity on the (i) Office of Foreign Assets Control Specially Designated Nations List, (ii) Bureau of Industry and Security&#8217;s Entity List, (iii) National Defense Authorization Act Lists, or (iv) SAM&#8217;s Denied Vendor List; and (7), any entity Controlled or Influenced by any entity meeting the definitions stated in Section 1.20(5) and Section 1.20(6) above.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.22.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Protected CRADA Information</u></b>&#8221;&nbsp;shall have the meaning as set forth in the CRADA, Article I, Section H.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.23.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Subject Invention</u></b>&#8221;&nbsp;shall have the meaning as set forth in the CRADA, Article I, Section I.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.24.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Sublicensee</u></b>&#8221;&nbsp;means any third party to whom Licensee has granted a Sublicense Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="3" data-prefix="Page " data-suffix="" style="text-align: right; font-size: 10pt; font-family: Times New Roman;">Page 3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="width: 100%;">
<div class="hf-row">
<div class="hf-cell" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; margin: 0pt; width: 99.9%; display: inline-block;">NREL License Agreement No. 24-00500</div>
</div>

<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: left; margin: 0pt; width: 99.9%; display: inline-block;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.25.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Sublicense Agreement</u></b>&#8221;&nbsp;means a past, present or future agreement in which Licensee:</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.25.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">grants or otherwise transfers any of the rights granted hereunder or other rights that are relevant to designing, developing, testing, making, using, or selling of Licensed Products,</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.25.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">agrees not to assert the Licensed Patent Rights or agrees not to sue, prevent, or seek a legal remedy for the practice of same, and</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.25.3.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">is under an obligation to do any of the foregoing, or to forebear from offering or doing any of the foregoing with any other entity, including licenses, option agreements, right of first refusal agreements, standstill agreements, settlement agreements or other agreements.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.26.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Sublicense Revenue</u></b>&#8221;&nbsp;means (i) royalty fees received by Licensee from non-Affiliate Sublicensees from the production and sale of Licensed Products, and (ii) the fair market cash value of any and all consideration received by Licensee from Sublicensees for the production and sale of Licensed Products under or otherwise in connection with its Sublicenses, including without limitation license issue fees, option fees and other licensing fees, milestone payments, equity or other payments of any kind whatsoever, or any other consideration, irrespective of the form of payment.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.27.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>Subsidiary</u></b>&#8221;&nbsp;of an entity means another entity, i.e. parent entity, who owns fifty percent (50%) or more of the voting shares and has control of the Subsidiary (but only as long as such corporation meets these requirements).</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.28.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<b><u>TRL</u></b>&#8221;&nbsp;means the scale used by DOE to systematically estimate the readiness of technology from conception to commercialization, iterating sequentially as follows: (i) TRL 1 (basic principles observed and reported); (ii) TRL 2 (technology concept and application formulated); (iii) TRL 3 (analytical and experimental proof of concept); (iv) TRL 4 (validation in laboratory environment);&nbsp;(v) TRL 5 (pre-pilot scale validation in relevant environment); (vi) TRL 6 (pilot prototype demonstration in relevant environment); (vii) TRL 7 (scaled-up commercial prototype in operational environment); (viii) TRL 8 (commercial system demonstration); (ix) TRL 9 (commercial maturity).</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Grants</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Grant.</u>&nbsp;Subject to Alliance&#8217;s rights in the Licensed Patent Rights and the terms and conditions of this Agreement, Alliance hereby grants to Licensee, and Licensee accepts, an <b>EXCLUSIVE </b>worldwide, subject to the geographic coverage of Licensed Patent Rights, right and license, subject to certain Government rights set forth below in Section 2.3,</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.1.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">to make, have made, use, import (subject to Section 2.4), or sell Licensed Products in the Field of Use; and,</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.1.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">to sublicense the rights granted herein to Permitted Entities to make, have made, use, import (subject to Section 2.4), or sell Licensed Products in the Field of Use, on and subject to terms and conditions which do not violate the terms of this Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Sublicense Agreements</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Licensee Affiliate</u>. Licensee shall have the right to issue to its Affiliate, Comstock Fuels Corporation (&#8220;<b><u>CFC</u></b>&#8221;), a single master exclusive Sublicense Agreement (&#8220;<b><u>Master</u></b><b>&nbsp;</b><b><u>Sublicense Agreement</u></b>&#8221;) on and subject to the terms and conditions of this Agreement, including, without limitation, this Section 2.2; provided, however, that (i) the Master Sublicense Agreement shall be on substantially the same terms and conditions as this Agreement, and (ii) all other consideration paid to Licensee under the Master Sublicense Agreement must be sufficient to pay all License Fees and other consideration due hereunder as if Licensee directly received the corresponding Net Sales and Sublicensing Revenue.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Prohibited Entities</u>. Licensee shall not sublicense or otherwise grant any rights granted to Licensee hereunder to Prohibited Entities or allow the rights granted hereunder to transfer to a Prohibited Entity. Licensee shall not grant a Sublicense Agreement to any Prohibited Entity or allow any of the rights granted to Licensee hereunder to be issued, at any tier, to any entity (i) operating, organized or headquartered in a DOE Country of Risk, or (ii) that is sanctioned or violating sanctions imposed by, at any level, the U.S. Government,&nbsp;including by the Department of Treasury, Office of Foreign Assets Control ("<b><u>OFAC</u></b>"). Licensee shall ensure, through an annual certification to Alliance, that all Sublicensees have not undergone a change in control to become a Prohibited Entity.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="4" data-prefix="Page " data-suffix="" style="text-align: right; font-size: 10pt; font-family: Times New Roman;">Page 4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="width: 100%;">
<div class="hf-row">
<div class="hf-cell" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; margin: 0pt; width: 99.9%; display: inline-block;">NREL License Agreement No. 24-00500</div>
</div>

<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: left; margin: 0pt; width: 99.9%; display: inline-block;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.3.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Foreign Entity Authorization</u>. Licensee shall not enter into Sublicense Agreements with Permitted Entities that are Foreign Entities or any other entities or persons that are Controlled or Influenced by one or more Foreign Entities without the prior written approval of Alliance, which shall not be unreasonably withheld. If Licensee intends to enter into a Sublicense Agreement with any Permitted Entity that is a Foreign Entity or any other entity or person that is Controlled or Influenced by one or more Foreign Entities, then Licensee shall submit a written request to that effect to Alliance (each, a &#8220;<b><u>Foreign Entity</u></b><b>&nbsp;</b><b><u>Authorization Request</u></b>&#8221;), including a reasonably sufficient description of the applicable facts and circumstances for Alliance to conduct its own direct evaluation. Alliance shall issue Licensee a written response within thirty (30) days of the date that any Foreign Entity Authorization Request is issued hereunder.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Required Sublicense Terms</u>. Unless otherwise agreed by the Parties in writing, all Sublicense Agreements entered into by Licensee hereunder must include the following terms and conditions (&#8220;<b><u>Required Terms</u></b>&#8221;):</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.1.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">provisions requiring the performance of obligations that are reasonably necessary for Licensee to meet its obligations under this Agreement;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.2.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">provisions requiring payment of sufficient Sublicense Revenue to meet applicable License Fee obligations hereunder;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.3.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">a prohibition on the grant of further sublicense agreements;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.4.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">a requirement that Licensed Products be substantially manufactured in the United States;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.5.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">a prohibition on the ability of any Sublicense Agreement or further sublicense agreement, at any tier, to be assigned or pledged as collateral; and,</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.6.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">provisions that are substantially the same as the following sections of this Agreement:</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.7.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 2.4&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;U.S. Manufacture</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.8.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 2.5&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Patent Marking</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.9.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 2.6&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Grant to Affiliates</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.10.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 4.1&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Annual Report</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.11.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 4.2&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Records and Audit</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.12.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 4.3&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Development and Commercialization</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.13.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 4.4&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Late Payments</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.14.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 4.5&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Currency</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.15.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 8.1&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Limitations of Liability</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.16.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 8.2&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;No Warranties</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.17.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 8.3&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Indemnification</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.18.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 8.4&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Insurance</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.19.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 9.1&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Responsibility for Patenting</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.20.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 10&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Term of Agreement and Early Termination</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.21.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 11&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Rights of Parties After Termination</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="5" data-prefix="Page " data-suffix="" style="text-align: right; font-size: 10pt; font-family: Times New Roman;">Page 5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="width: 100%;">
<div class="hf-row">
<div class="hf-cell" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; margin: 0pt; width: 99.9%; display: inline-block;">NREL License Agreement No. 24-00500</div>
</div>

<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: left; margin: 0pt; width: 99.9%; display: inline-block;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.22.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 12&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Force Majeure</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.23.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 13&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Notices and Payments</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.24.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 14&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Non-Abatement of Royalties</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.25.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 15&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Confidential Information</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.26.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 16&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Waivers</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.27.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 17&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Entire Agreement and Legal Amendments</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.28.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 18&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Headings</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.29.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 19&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Assignment and Change of Control</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.30.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 20&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Disputes and Governing Laws</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.4.31.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 21&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Non-Use of Names</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.5.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Request for Alliance Approval</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.5.1.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Sublicense Variance Request</u>. In connection with any Sublicense Agreement intended to be issued hereunder, if Licensee determines that material variance from the Required Terms is required, then Licensee may submit a written request to that effect to Alliance (each, a &#8220;<b><u>Variance Request</u></b>&#8221;), including a reasonable description of the applicable facts and circumstances.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.5.2.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Alliance Response</u>. Within thirty (30) days of the date that any Variance Request is received by Alliance hereunder, Alliance shall issue Licensee a written response, including, without limitation, Alliance&#8217;s acceptance, conditional acceptance, rejection, proposed alternative modification, and/or compliance determination, to be determined by Alliance in its sole discretion, and Alliance&#8217;s determination if additional approval by DOE is required.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.6.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Request for DOE Approval</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.6.1.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Joint Modification Request</u>. If Alliance has conditionally accepted any Variance Request by Licensee under Section 2.2.5.1 that is subject to DOE approval, then Licensee and Alliance shall cooperate in good faith to submit a joint request to the DOE to modify the applicable requirement.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.6.2.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Joint Modification Request; Manufacturing of Licensed Products</u>. Licensee and Alliance shall cooperate in good faith to prepare and submit a joint request to the DOE to modify the requirement stated in Section 2.4 hereof for the production of Licensed Products by Foreign Entities that are not Prohibited Entities, and other entities or persons that are Controlled or Influenced by one or more Foreign Entities that are not Prohibited Entities.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.7.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Conditions for Effectiveness</u>. For avoidance of doubt, and notwithstanding anything stated herein, any Sublicense Agreement issued by Licensee hereunder which does not comply with this Agreement shall be null and void, and shall constitute cause for immediate termination of this Agreement under Section 10 hereof. Licensee agrees and acknowledges that the terms and conditions of this Agreement are reasonably necessary to ensure compliance with applicable Government requirements.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.8.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Responsibilities</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.8.1.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Breach by Sublicensees</u>. Licensee shall assume responsibility for its Sublicensees, and hereby agrees that any act or omission of a Sublicensee that would be a breach of this Agreement will be deemed a breach of this Agreement by Licensee.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="6" data-prefix="Page " data-suffix="" style="text-align: right; font-size: 10pt; font-family: Times New Roman;">Page 6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="width: 100%;">
<div class="hf-row">
<div class="hf-cell" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; margin: 0pt; width: 99.9%; display: inline-block;">NREL License Agreement No. 24-00500</div>
</div>

<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: left; margin: 0pt; width: 99.9%; display: inline-block;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.8.2.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Annual Reporting</u>. Licensee shall require its Sublicensees to provide Licensee with an annual report according to the requirement in Section 4.1, such that Licensee can in turn satisfy its annual report requirements hereunder.</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.8.3.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Non-Cash Consideration</u>. Licensee shall not receive, or agree to receive, anything of value in lieu of cash as consideration from a third party under a Sublicense Agreement granted pursuant to Section 2.2.</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.8.4.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>New Sublicense Notification</u>. Licensee shall provide Alliance with written notice within ten (10) days of executing any Sublicense Agreement hereunder, including a copy of the applicable Sublicense Agreement and a reasonable written summary of the Sublicensee and the essential terms of the Sublicense Agreement (&#8220;<b><u>New Sublicense Notice</u></b>&#8221;).</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.2.8.5.</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 79%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Further Assurances</u>. Licensee agrees to execute, acknowledge and deliver all such further instruments, and to do all such other acts as may be reasonably necessary or appropriate in order to carry out the intent and purposes of this Agreement, including, without limitation, in connection with the execution and administration of Sublicense Agreements hereunder.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.3.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Government Rights</u>. The right and license granted in Section 2.1 is subject to the following Government rights: (i) the Government has a paid-up, royalty-free, worldwide, nontransferable, irrevocable license to practice or have practiced by or on behalf of the Government the inventions covered by the Licensed Patent Rights, and (ii) the DOE&#8217;s march-in rights as required by the Prime Contract and 35 U.S.C. &#167;&nbsp;203. Alliance and MIT retain the right to practice or allow any other non- profit research institution to practice the Licensed Patent Rights for research, teaching, and educational purposes.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.4.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>U.S. Manufacture</u>. Licensee agrees that any Licensed Products shall be substantially manufactured in the United States.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.5.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Patent Marking</u>. Licensee shall mark all Licensed Products made or sold in the U.S. with &#8220;Patent Pending&#8221;&nbsp;prior to patent issuance and with the appropriate patent number(s) upon issuance in accordance with 35 U.S.C. &#167;287(a) and will mark all Licensed Products made or sold in other countries in accordance with laws and regulations then applicable in each such country. Licensee acknowledges that it will be liable to Alliance for infringement damages lost due to improper or defective patent marking.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.6.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Grant to Affiliates</u>. Licensee&#8217;s Affiliates may receive rights to the Licensed Patent Rights upon the written consent of Alliance, which shall not be unreasonably withheld; provided, however, that (i) any authorized Affiliate(s) shall be subject to the terms and conditions hereof; and (ii), Licensee shall assume responsibility for such Affiliate(s), and hereby agrees that any act or omission of an Affiliate that would be a breach of this Agreement will be deemed a breach of this Agreement by Licensee.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.7.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>CRADA Subject Inventions</u>. Alliance and Licensee rights in Subject Inventions conceived or first reduced to practice under the CRADA will be added to Exhibit A for no additional consideration upon execution by the Parties of a written amendment hereto.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.8.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Protected CRADA Information</u>. In the event that Comstock desires to use Alliance Protected CRADA Information for purposes other than those set forth in Article VII, Section C of the CRADA, such Protected CRADA Information shall be added to Exhibit A for no additional consideration upon execution by the Parties of a written amendment hereto.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 8pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>3.</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Financial Obligations</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>3.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Consideration</u>. Licensee shall pay to Alliance the License Fees at terms and conditions as set forth herein.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>3.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>No Royalties for Government Sales.</u>&nbsp;Licensee and its Sublicensees shall owe no royalties to Alliance on any acquisitions involving Government funds if such sales reflect a discount that is greater than&nbsp;or equal to the amount Licensee would owe to Alliance under this license, because of the Government&#8217;s retained license in the Licensed Patent Rights.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="7" data-prefix="Page " data-suffix="" style="text-align: right; font-size: 10pt; font-family: Times New Roman;">Page 7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="width: 100%;">
<div class="hf-row">
<div class="hf-cell" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; margin: 0pt; width: 99.9%; display: inline-block;">NREL License Agreement No. 24-00500</div>
</div>

<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: left; margin: 0pt; width: 99.9%; display: inline-block;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>3.3.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Sales Reports.</u>&nbsp;Licensee shall report the Net Sales price paid by the purchaser for acquisitions or use of the Licensed Products involving Government funds under the Records, Reports, and Royalty Payments Section of this Agreement. This report will also include (a) a Government control number (if available); and (b) identification of the Government agency for each sale.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>4.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Records, Reports, and Royalty Payments</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>4.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Annual Report</u>. Licensee shall provide Alliance with a written report certified by an officer of Licensee that complies with the requirements of the Notices and Payments Section (Section 13), Section 3.3 and <b><u>Exhibit D</u></b><b>&nbsp;</b>of this Agreement no later than thirty (30) days after the end of each calendar year for the life of this Agreement that identifies the following information for the immediately preceding calendar year: (a) all Net Sales received by Licensee and its Affiliates in&nbsp;U.S. Dollars itemized by domestic and/or foreign rights that are subject to this Agreement including acquisitions involving Government funds and all export Net Sales received by Licensee and its Affiliates, and if none to so indicate; (b) all Net Sales received by non-Affiliate Sublicensees in U.S. Dollars, itemized by domestic and/or foreign rights that are subject to this Agreement including acquisitions involving Government funds and all export Net Sales received by non-Affiliate Sublicensees, and if none to so indicate; (c) amount of each payment due Alliance for License Fees under Section 3.1 hereof; and (d), a certification, made by an officer of Licensee, that Licensee and Sublicensees are complying with the substantial U.S. Manufacturing requirements of this Agreement. Licensee shall provide, along with the annual written report the full payment of License Fees due in U.S. Dollars, for the preceding calendar year, pursuant to the terms of this Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>4.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Records and Audit</u>. Licensee agrees to: (a) keep adequate and sufficiently detailed records to demonstrate Licensee&#8217;s compliance with the obligations of this Agreement (including the requirements of Exhibits C and D), including financial records to demonstrate its financial capability; (b) within forty-eight (48) hours provide such records for inspection and copying by Alliance&#8217;s authorized representatives, with reasonable notice, at any time during Licensee&#8217;s regular business hours; and (c), make any records required to be generated or maintained under this Agreement available for inspection by Alliance&#8217;s authorized representatives for three (3) years after the last royalty period to which the records refer. In the event an examination of Licensee&#8217;s records reveals: (i) noncompliance with the terms of this Agreement or (ii) an underpayment of more than five percent (5%) of the accurate amounts due hereunder, Licensee shall pay all costs incurred by Alliance related to the examination or records in addition to paying the balance due, plus any applicable interest at the rate specified in Section 4.6 herein below.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>4.2.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Licensee agrees that it shall also provide Alliance with any additional records that Alliance reasonably determines are necessary to verify any records that Licensee is required to generate or maintain to fulfill the requirements listed in Exhibits C and D.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>4.2.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Licensee agrees to make any records that it is required to generate or maintain under the terms of this Agreement available for inspection by Alliance&#8217;s authorized representatives for three (3) years after the last royalty period to which the records refer.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>4.2.3.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">At all times during the term of this Agreement, Licensee shall maintain the financial capability to meet the Diligence Obligations of this Agreement. Upon request of Alliance, Licensee will provide any requested assurances and disclosures, including, but not limited to, financial records that will demonstrate its financial capability.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>4.3.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Development and Commercialization</u>. During the effective term of this Agreement, Licensee shall provide a written report on or before January 31st of each year describing the Licensee&#8217;s progress during the preceding year toward achievement of the Commercialization Milestones. Such report shall include, at a minimum, information sufficient to enable Alliance to satisfy relevant reporting requirements of the U.S. government and to ascertain Licensee&#8217;s progress toward meeting the Commercialization Milestones.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="8" data-prefix="Page " data-suffix="" style="text-align: right; font-size: 10pt; font-family: Times New Roman;">Page 8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="width: 100%;">
<div class="hf-row">
<div class="hf-cell" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; margin: 0pt; width: 99.9%; display: inline-block;">NREL License Agreement No. 24-00500</div>
</div>

<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: left; margin: 0pt; width: 99.9%; display: inline-block;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>4.4.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Payments</u>. <b>ALLIANCE WILL NOT SEND INVOICES FOR PAYMENTS DUE ON A FIXED SCHEDULE. IT IS LICENSEE</b>&#8217;<b>S RESPONSIBILITY TO MAKE ALL PAYMENTS IN ACCORDANCE WITH THIS AGREEMENT AND ALL LATE PAYMENTS WILL BE CHARGED INTEREST IN ACCORDANCE WITH SECTION 4.6 OF THIS AGREEMENT.</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>4.5.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Late Payments</u>. If Licensee fails to make any payment to Alliance that may be required under this Agreement within the time period prescribed for such payment, then the unpaid amount shall bear interest at the rate of one-and-one half percent (1.5%) per month, or other authorized statutory rate, if higher, from the date when the payment was due until payment in full, with interest, is made. Should Licensee have need to delay a payment when due, Alliance will consider Licensee&#8217;s needs as presented, in writing to Alliance at the address set forth in Section 12.1, by Licensee and received by Alliance thirty (30) days before the required reporting and payment date. Under such conditions, Alliance may, at its sole discretion, extend the date upon which an annual payment is required.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>4.6.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Currency</u>. Licensee shall make all financial payments to the order of Alliance in U.S. dollars in accordance with Exhibit B and this Section 4.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>5.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Diligence</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>5.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Commercialization.</u>&nbsp;In consideration of the rights and license granted herein, Licensee shall use its best efforts on a diligent and aggressive basis to develop, commercialize, manufacture, market, sell, sublicense, and maximize market adoption of Licensed Products in the Field of Use, including, without limitation, by satisfaction of the commercialization milestones set forth in Exhibit C hereto, which is hereby incorporated by reference herein (&#8220;<b><u>Commercialization Milestones</u></b>&#8221;). The efforts of Sublicensees will be considered the efforts of Licensee for the purposes of this Section 5.1.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>5.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Impact of Failure to Meet Commercialization Milestones</u>. Alliance shall have the right to modify the <b>EXCLUSIVE </b>scope of the License Agreement to <b>NON-EXCLUSIVE </b>upon written notice to Licensee if Licensee fails (i) to satisfy the Commercialization Milestones and (ii) to cure any such failure within 180 days of receiving Alliance&#8217;s written notice describing (a) Alliance&#8217;s compliance determination and (b) the applicable facts and circumstances. For avoidance of doubt, a failure to satisfy the Commercialization Milestones shall not constitute an event of default hereunder, subject to Section 10.2.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>6.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Infringement by Third Parties</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>6.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Notice</u>. If either Party becomes aware of any actual or potential infringement of the Licensed Patent Rights within the Field of Use, such Party shall promptly notify the other Party in writing of such fact and any relevant details. In the event any Licensed Patent Rights are infringed by an unlicensed third party, Licensee and Alliance shall have the right to abate or prevent such infringement, subject to DOE approval, as follows:</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>6.1.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Action by Licensee</u>. Licensee shall have the first right to take appropriate action to abate or prevent an infringement of Licensed Patent Rights within the Field of Use (&#8220;<b><u>Action</u></b>&#8221;). Before commencing any Action, Licensee will first consult with Alliance and the DOE and obtain written authorization from the DOE to take such Action. In the event DOE authorizes Licensee to undertake an infringement suit, Licensee shall further consult with Alliance to determine if Alliance wishes to voluntarily enter into such suit.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 108pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>6.1.1.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Suit brought solely by Licensee</u>. In the event Alliance declines to voluntarily enter into an infringement suit, Licensee may undertake such suit. If Alliance is legally required to be named as a party to such suit for Licensee to have standing, Licensee may join Alliance to such suit in name only, provided that Licensee shall not be acting as the agent, or in any way on behalf of Alliance. Alliance will cooperate in such suit solely to the extent necessary to maintain standing as reasonably requested by Licensee, at Licensee&#8217;s sole expense. Alliance shall have the right to be represented by counsel at the suit proceedings and to participate therein at its own cost. If Licensee exercises its right to take any Action against a third party, Licensee shall be obligated to defend any cross claim, counterclaim, administrative action or action for declaratory judgment related to the Licensed&nbsp;Patent Rights and shall not take any position or action that would have an adverse effect on the Licensed Patent Rights or scope, claims, validity, or enforceability thereof. Licensee shall not have the right to name or enjoin MIT in any infringement suit without MIT&#8217;s prior express written consent.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="9" data-prefix="Page " data-suffix="" style="text-align: right; font-size: 10pt; font-family: Times New Roman;">Page 9</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="width: 100%;">
<div class="hf-row">
<div class="hf-cell" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; margin: 0pt; width: 99.9%; display: inline-block;">NREL License Agreement No. 24-00500</div>
</div>

<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: left; margin: 0pt; width: 99.9%; display: inline-block;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 108pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>6.1.1.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Suit brought by Licensee and Alliance</u>. If Alliance exercises the option to join such action, Alliance and Licensee shall negotiate in good faith to execute a joint litigation agreement. The joint litigation agreement shall include terms for the defense of any cross claim, counterclaim, administrative action or action for declaratory judgment related to the Licensed Patent Rights.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>6.1.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Settlements</u>. Licensee shall not settle, enter into voluntary disposition of, or compromise any suit in a manner that imposes any obligations or restrictions on Alliance or grants any rights to the Licensed Patent Rights without Alliance&#8217;s prior written permission. Any agreement made by Licensee for the purposes of settling an infringement suit hereunder or other related disputes will comply with the requirements of Section 2.2</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 108pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>6.1.2.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Suit brought solely by Licensee</u>. In DOE authorized infringement suits brought solely by Licensee pursuant to Section 6.1.1.1 above, all costs and expenses associated therewith shall be the responsibility of Licensee alone, and Licensee is entitled to reimburse its expenses out of any sums recovered from settlements, damages or other monetary awards. After such reimbursement, remaining sums from any settlements, damages or other monetary awards shall be deemed as Sublicensing Revenue.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 108pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>6.1.2.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Suit brought by Licensee and Alliance</u>. If the suit is brought by both Licensee and Alliance pursuant to Section 6.1.1.2 above, both Licensee and Alliance are entitled to reimburse their expenses out of any sums recovered from settlements, damages, or other monetary rewards. After such reimbursement, remaining sums from any settlements, damages or other monetary awards shall be shared among Licensee and Alliance, with Licensee receiving fifty percent (50%) and Alliance receiving fifty percent (50%). Such sums received by Licensee shall not be deemed as sublicensing revenue.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>6.1.3.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Suit by Alliance</u>. Under Section 6.1.1 above, if Licensee does not take appropriate action to abate or prevent an infringement within one hundred twenty (120) days after receiving notice, Alliance shall have the second right, but not the obligation, to file suit in its own name by counsel of its choice. The cost and expenses of all suits brought by Alliance under Section 6.1.3 shall be the responsibility of Alliance and as a result, Alliance shall be entitled to receive and retain for its own use any settlement amount or remaining damages awarded in such suit.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>6.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>No Responsibility by Alliance and Government</u>. Alliance and the Government shall not be liable for any costs or losses incurred as a result of an action for infringement brought against Licensee and/or its Sublicensees as a result of Licensee&#8217;s exercise of any right granted under this Section 6, and Licensee shall indemnify and hold Alliance, the Government, their officers, employees and agents harmless against all liability, expenses and costs, including attorneys&#8217;&nbsp;fees incurred as a result of any such suit.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>6.3.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Consequences of a Patent Challenge</u>. If Licensee or any of its Affiliates or Sublicensees challenge the validity, patentability, scope, priority, construction, non-infringement, inventorship, ownership, or enforceability of the Patent Rights or assists another party in so challenging the Patent Rights (except as required pursuant to a court order or subpoena), then all payments due under this Agreement shall be doubled for the duration of the term of this Agreement. In the event that such a patent challenge is successful, Licensee will have no right to recoup any payments made during the period of challenge. In the event that a patent challenge is unsuccessful, Licensee shall reimburse Alliance and MIT for all reasonable legal fees and expenses incurred in their defense against the patent challenge.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="10" data-prefix="Page " data-suffix="" style="text-align: right; font-size: 10pt; font-family: Times New Roman;">Page 10</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="width: 100%;">
<div class="hf-row">
<div class="hf-cell" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; margin: 0pt; width: 99.9%; display: inline-block;">NREL License Agreement No. 24-00500</div>
</div>

<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: left; margin: 0pt; width: 99.9%; display: inline-block;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>7.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Representations and Warranties</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>7.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Alliance represents and warrants that Alliance can grant the rights, licenses, and privileges granted by this Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>7.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Alliance represents and warrants that Alliance has no actual knowledge of any infringement claims filed against Alliance for practicing the Licensed Patent Rights anywhere in the world.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>7.3.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Except as set forth in this Section 7, Alliance makes NO REPRESENTATIONS OR WARRANTIES, express or implied, with regard to infringement of any Licensed Patent Rights.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>7.4.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Licensee represents and warrants that it shall not export any technical information (or the direct product thereof) furnished to Licensee, either directly or indirectly by Alliance in the grant of a license to the Licensed Patent Rights, from the United States of America, directly or indirectly without first complying with all requirements of the Export Administration Regulations, including the requirement for obtaining any export license, as applicable.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>7.5.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Licensee warrants that it will not grant any rights inconsistent with the terms, scope and Field of Use of this Agreement, and shall not grant rights to any Sublicensee that Alliance itself would be prohibited from entering into by applicable laws, rules and regulations.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>7.6.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Licensee agrees to indemnify, defend, and hold harmless Alliance, DOE and the Government, its officers, agents and employees from all liability involving the violation of such export regulations, either directly or indirectly, by Licensee or its Sublicensees.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><font style="color:#000000;"><b>7.7.</b></font></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><font style="color:#000000;">Licensee acknowledges it may be subject to criminal liability under U.S. laws for Licensee&#8217;s failure to obtain any required export licenses.</font></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>7.8.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Licensee represents that Licensee is not a Prohibited Entity and agrees that it is a material breach of this Agreement if Licensee becomes a Prohibited Entity.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>8.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Limitations of Warranties, Indemnification and Insurance</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>8.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Neither NREL, Alliance, MIT, the DOE, the Government nor persons acting on their behalf will be responsible for any injury to or death of persons, or damage to or destruction of any property, or for any other loss, damage, or injury of any kind whatsoever resulting from Licensee's manufacture, use, importation or sale of the Licensed Patent Rights or Licensed Products, in whatever form furnished hereunder, absent any negligent act or omission on the part of NREL, Alliance, MIT, DOE and/or the Government.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>8.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>THE PARTIES AGREE THAT NEITHER NREL, ALLIANCE, MIT, DOE, THE GOVERNMENT, NOR PERSONS ACTING ON THEIR BEHALF MAKE ANY WARRANTY, EXPRESS OR IMPLIED:</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>8.2.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>WITH RESPECT TO THE MERCHANTABILITY, ACCURACY, COMPLETENESS, OR USEFULNESS OF ANY LICENSED PATENTS, PATENT APPLICATIONS, ISSUED PATENTS, LICENSED PRODUCTS, OR NREL PROTECTED INFORMATION FURNISHED HEREUNDER;</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>8.2.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>THAT THE USE OF ANY LICENSED PATENTS, PATENT APPLICATIONS, ISSUED PATENTS, LICENSED PRODUCTS, OR NREL PROTECTED INFORMATION MAY NOT INFRINGE ANY PRIVATELY OWNED RIGHTS;</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>8.2.3.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>THAT ANY LICENSED PATENTS, PATENT APPLICATIONS, ISSUED PATENTS, LICENSED PRODUCTS, OR NREL PROTECTED INFORMATION FURNISHED HEREUNDER WILL NOT RESULT IN INJURY OR DAMAGE WHEN USED FOR ANY PURPOSE; OR</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>8.2.4.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>THAT ANY LICENSED PATENTS, PATENT APPLICATIONS, ISSUED PATENTS, LICENSED PRODUCTS, OR NREL PROTECTED INFORMATION FURNISHED HEREUNDER WILL ACCOMPLISH THE INTENDED RESULT&nbsp;OR ARE SAFE OR FIT FOR ANY PURPOSE, INCLUDING THE INTENDED OR PARTICULAR PURPOSE;</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="11" data-prefix="Page " data-suffix="" style="text-align: right; font-size: 10pt; font-family: Times New Roman;">Page 11</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="width: 100%;">
<div class="hf-row">
<div class="hf-cell" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; margin: 0pt; width: 99.9%; display: inline-block;">NREL License Agreement No. 24-00500</div>
</div>

<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: left; margin: 0pt; width: 99.9%; display: inline-block;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>8.2.5.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>NREL, DOE, ALLIANCE, MIT, AND THE GOVERNMENT HEREBY SPECIFICALLY DISCLAIM ANY AND ALL WARRANTIES, EXPRESS OR IMPLIED, FOR ANY LICENSED PATENTS, PATENT APPLICATIONS, ISSUED PATENTS, NREL PROTECTED INFORMATION, OR LICENSED PRODUCTS MANUFACTURED, USED, OR SOLD BY LICENSEE.</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>8.2.6.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>NEITHER NREL, DOE, ALLIANCE, MIT, NOR THE GOVERNMENT SHALL BE LIABLE FOR LOST PROFITS, LOST SAVINGS, SPECIAL, CONSEQUENTIAL, INCIDENTAL OR OTHER INDIRECT DAMAGES IN ANY EVENT, EVEN IF SUCH PARTY IS MADE AWARE OF THE POSSIBILITY THEREOF.</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>8.3.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Except for any liability resulting from any negligent acts or omission of NREL, the DOE, MIT, the Government or Alliance, Licensee shall indemnify and hold harmless NREL, the DOE, MIT, the Government and Alliance, and their officers, employees, and agents, for all damages, costs, and expenses, including attorneys' fees, arising from death, personal injury or property damage to third parties occurring as a result of the commercialization and utilization of the Licensed Patent Rights by Licensee and its Sublicensees, if any, including but not limited to, the making, using, selling, or exporting of Licensed Products by or on behalf of Licensee, its assignees, or licensees which was derived from the work or activities performed under this Agreement. This indemnification shall include, but not be limited to, indemnification for any product liability resulting from the commercialization and utilization of the Licensed Patent Rights by Licensee and its Sublicensees, if any. The indemnity set forth in this Section 8.3. shall apply only if Licensee shall have been informed as soon as practical by NREL, Alliance and/or the DOE or the Government of the action alleging such claim and shall have been given an opportunity, to the extent afforded by applicable laws, rules, or regulations, to participate in and control its defense, and NREL, Alliance and/or the DOE or the Government shall have provided reasonably available information and reasonable assistance (at Licensee&#8217;s costs) as requested by Licensee. No settlement for which Licensee shall be responsible shall be made without Licensee's consent unless required by final decree of a court of competent jurisdiction.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>8.4.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Beginning at the time when any Licensed Products are being distributed or sold (including for the purpose of obtaining regulatory approvals) Licensee shall, at its sole cost and expense, procure and maintain commercial general liability insurance in amounts not less than $3,000,000 per incident and $5,000,000 annual aggregate, and Licensee shall have the Government, Alliance, MIT, and their respective officers, employees and agents named as additional insureds. Such commercial general liability insurance shall provide (i) product liability coverage; (ii) broad form contractual liability coverage for Licensee's indemnification under this Agreement; and (iii) coverage for litigation costs. The minimum amounts of insurance coverage required shall not be construed to create a limit of Licensee's liability with respect to its indemnification obligations under this Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>8.5.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Licensee shall provide Alliance with written evidence of such insurance upon Alliance&#8217;s written request. Licensee shall provide Alliance with written notice of at least fifteen (15) days before a material change in such insurance.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>8.6.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Licensee shall maintain such commercial general liability insurance beyond the expiration or termination of this Agreement during (a) the period that any Licensed Products are practiced or processes covered by this Agreement are being commercially distributed or sold by Licensee or by a Sublicensee, if any, or agent of Licensee; and (b) the five (5) year period immediately after such period described in subsection (a).</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>8.7.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">MIT is not a party to this agreement and the Parties agree that MIT has no liability to Licensee, Affiliates of Licensee, or Sublicensees under this Agreement. The Parties agree, however, that MIT is an intended third-party beneficiary of this Agreement and certain provisions are for the benefit of MIT and are enforceable against Licensee by MIT in its own name as if MIT were a signatory hereto.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="12" data-prefix="Page " data-suffix="" style="text-align: right; font-size: 10pt; font-family: Times New Roman;">Page 12</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="width: 100%;">
<div class="hf-row">
<div class="hf-cell" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; margin: 0pt; width: 99.9%; display: inline-block;">NREL License Agreement No. 24-00500</div>
</div>

<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: left; margin: 0pt; width: 99.9%; display: inline-block;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>9.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Reimbursement of Patent Costs and Technical Assistance</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>9.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Responsibility for Patenting</u>. Alliance is the owner of the Licensed Patent Rights and shall have exclusive responsibility for the preparation, filing, prosecution and maintenance of the Licensed Patent Rights, including choice of patent counsel. However, Alliance shall keep Licensee informed of patent prosecution, will seek Licensee&#8217;s comments and suggestions prior to taking material actions for the same, and will take all reasonable prosecution actions recommended by Licensee that would expand the scope of the rights sought. Licensee shall cooperate with Alliance to ensure that the claims for each Licensed Patent reflects and will reflect, to the extent practicable and to the best of Licensee&#8217;s knowledge, all items of commercial interest to Licensee that are contemplated to be sold or procedures to be practiced under this Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>9.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Past Patenting Costs.</u>&nbsp;Reserved.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>9.3.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Ongoing Patenting Costs</u>. Licensee will reimburse Alliance for all Patenting Costs for all Licensed Patent Rights accruing on and after the Effective Date of this Agreement. Invoices for such costs will not exceed actual costs and are due and payable no later than thirty (30) days after receipt of invoices by Licensee.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>9.4.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Failure to Pay Patenting Costs.</u>&nbsp;If Licensee declines to pay in full any Patenting Costs within the period specified in Section 9.3 which are necessary to the protection of certain rights at issue or if Licensee enters a case under the Bankruptcy Code of 1978, Alliance shall have the right to (i) abandon some or all of such rights at Alliance&#8217;s sole discretion, or (ii) incur those costs at its own expense; in either case, Alliance may exclude such rights from the rights granted hereunder. In such event, Alliance shall be free to license such rights to third parties without further obligation to Licensee.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>9.5.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Technical Assistance.</u>&nbsp;Alliance agrees, upon the written request of Licensee, to assist Licensee in obtaining technical assistance from NREL subject to the availability of the required resources and under the appropriate agreements. Licensee shall pay the full cost in accordance with the Prime Contract with the Government for such technical assistance.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>10.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Term of Agreement and Early Termination</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>10.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Term.</u>&nbsp;Subject to early termination as set forth in this Section and the terms and conditions set forth in Exhibits C and D, this Agreement shall be effective for as long as the Licensed Patent Rights are pending or enforceable.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>10.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Right to Terminate with Cure Period.</u>&nbsp;Either Party shall have the right to terminate this Agreement with cause and without judicial resolution upon written notice to the other after the non-breaching Party notifies the asserted breaching Party of a breach of any provision of this Agreement and the asserted breach has not been cured by the asserted breaching Party within sixty (60) calendar days from receipt of such notice (&#8220;<b><u>Cure Period</u></b>&#8221;). If at the end of the Cure Period the asserted breach has not been cured and there remains a dispute or controversy, the Parties may agree to seek to resolve the matter through the use of the procedures set forth in Section 19.1 below. If Alliance is the non-breaching Party under this Section 10.2, then Licensee shall, within thirty (30) calendar days, owe Alliance all payments due, including but not limited to then appropriate Patenting Cost reimbursements and License Fees. Licensee acknowledges and agrees that Alliance shall be entitled to seek any additional remedies available at law to Alliance for Licensee&#8217;s breach of this Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>10.3.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Termination for Loss of Patents.</u>&nbsp;This Agreement shall terminate automatically upon a final adjudication of invalidity, unenforceability, or the extinguishment of all Licensed Patent Rights, for any reason.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>10.4.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Early Termination.</u>&nbsp;If Licensee fails to satisfy the requirements of Section 2.4, Section 19.2, Exhibits C, D, or E, then Alliance shall have the right, to exercise at its sole discretion with thirty (30) days written notice to Licensee, to terminate this Agreement in accordance with its early termination requirements.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>10.5.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Termination for Improper Transfer.</u>&nbsp;Alliance, at its sole discretion, may immediately terminate this Agreement upon any attempted transfer of Licensee's interest in this Agreement, in whole or in part, to any other party except as may be otherwise permitted by the terms of this Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="13" data-prefix="Page " data-suffix="" style="text-align: right; font-size: 10pt; font-family: Times New Roman;">Page 13</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="width: 100%;">
<div class="hf-row">
<div class="hf-cell" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; margin: 0pt; width: 99.9%; display: inline-block;">NREL License Agreement No. 24-00500</div>
</div>

<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: left; margin: 0pt; width: 99.9%; display: inline-block;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>10.6.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Termination for Actions of Licensee.</u>&nbsp;Licensee agrees that this Agreement shall automatically terminate if Licensee attempts, in any way, to pledge its rights under this Agreement as collateral to a third party or fails to report a Change in Control event to Alliance and DOE according to Section 19.3.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>10.7.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Termination for Bankruptcy.</u>&nbsp;Licensee will notify Alliance at least ten (10) business days prior to voluntarily filing for bankruptcy. Alliance may terminate this Agreement upon notice to Licensee if Licensee becomes insolvent, is adjudged bankrupt, applies for judicial or extra-judicial settlement with its creditors, makes an assignment for the benefit of its creditors, voluntarily files for bankruptcy or has a receiver or trustee (or the like) in bankruptcy appointed by reason of its insolvency, or in the event an involuntary bankruptcy action is filed against Licensee and not dismissed within ninety (90) days, or if Licensee becomes the subject of liquidation or dissolution proceedings or otherwise discontinues business.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>10.8.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Termination by Licensee.</u>&nbsp;Licensee may terminate this Agreement without cause if Licensee provides Alliance with sixty (60) days prior notice and pays Alliance: (a) all Patenting Cost reimbursement, as applicable, and all upfront fees due at the time of termination; and (b) all accrued continuous royalties due at the end of the accounting period of such termination.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>10.9.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Reporting Obligations on Termination.</u>&nbsp;Upon termination of this Agreement for any reason whatsoever, Licensee shall report and pay to Alliance, within thirty (30) days of such termination, any financial obligations including, but not limited to, fees, payments, royalties, reimbursements, interest, and other forms of consideration, due and owing Alliance.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>11.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Rights of Parties after Termination</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>11.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Responsibility for Actions Prior to Termination.</u>&nbsp;Neither Party shall be relieved of any obligation or liability under this Agreement arising from any act or omission committed prior to termination.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>11.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Effect of Termination on Sublicense Agreements</u>. Upon termination of this Agreement, then- existing Sublicense Agreements granted by Licensee in compliance with this Agreement that are in good standing shall survive termination, but only with respect to the respective Sublicensee&#8217;s then- existing facilities for production and/or sales of Licensed Products (each, a &#8220;<b><u>Surviving Sublicense</u></b><b>&nbsp;</b><b><u>Agreement</u></b>&#8221;), and only for so long as Alliance continues to receive all License Fees and other amounts required to be paid hereunder; provided, however, that:</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>11.2.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Surviving Sublicensee is not violating any of the terms and conditions of this Agreement as if it was an original party to the Agreement;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>11.2.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Surviving Sublicensee shall not be owned, Controlled, or Influenced by Prohibited Entities;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>11.2.3.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Surviving Sublicensee shall not be owned, Controlled, or Influenced by Foreign Entities, without the prior written approval of Alliance, which shall not be unreasonably withheld;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>11.2.4.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Surviving Sublicensee must comply with the Required Terms stated in Section 2.2 hereof unless otherwise agreed in writing by Alliance in its sole and exclusive discretion; and,</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>11.2.5.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">the surviving rights granted under this Section 11.2 for any Surviving Sublicensee under a Sublicense Agreement shall expire upon termination or expiration of the applicable then- existing surviving Sublicense Agreement for the Surviving Facility.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>11.3.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Transfer of Rights.</u>&nbsp;The rights and remedies granted herein, and any other rights or remedies which the Parties may have, either at law or in equity, are cumulative and not exclusive of others. On any termination, Licensee shall duly account to Alliance and transfer to it all rights to which Alliance may be entitled under this Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>11.4.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Survival.</u>&nbsp;The following Sections are intended to survive the termination of this Agreement: 2.4, 2.5 (if applicable), 3, 4, 7, 8, 9, 10, 11, 15, 16, 17, 19, and 20.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="14" data-prefix="Page " data-suffix="" style="text-align: right; font-size: 10pt; font-family: Times New Roman;">Page 14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="width: 100%;">
<div class="hf-row">
<div class="hf-cell" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; margin: 0pt; width: 99.9%; display: inline-block;">NREL License Agreement No. 24-00500</div>
</div>

<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: left; margin: 0pt; width: 99.9%; display: inline-block;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>12.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Force Majeure.</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>12.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">No failure or omission by Alliance or by Licensee in the performance of any obligation under this Agreement shall be deemed a breach of this Agreement or create any liability if the same shall arise from acts of God, acts or omissions of any government or agency thereof, compliance with rules, regulations, or orders of any governmental authority or any office, department, agency, or instrumentality thereof, fire, storm, flood, earthquake, accident, acts of the public enemy or terrorism, war, rebellion, insurrection, riot, sabotage, invasion, pandemic, quarantine, restriction, transportation embargoes, or failures or delays in transportation. The circumstances surrounding such failure or omission shall be communicated to the affected Party in writing within fifteen (15) business days of such event. Notwithstanding the above, the following shall not be considered a force majeure event: compliance by Licensee with rules, regulations, or orders of any governmental authority of a DOE Country of Risk, or any office, department, agency, or instrumentality thereof, that results in a failure or omission by Licensee in the performance of any obligation of this Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>13.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Notices and Payments</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>13.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">All notices and reports shall be addressed to the Parties as follows:</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">If to Alliance:</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 108pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">National Renewable Energy Laboratory</p>

			<p style="margin: 0pt; text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">15013 Denver West Parkway</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 81pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Golden, Colorado 80401</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 81pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Attention:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Technology Transfer Office</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 81pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">Telephone No.&nbsp; &nbsp; &nbsp; (303) 275-4435</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 81pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Facsimile No.:&nbsp; &nbsp; &nbsp; (303) 384-7499</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 81pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">E-mail Contact:&nbsp; &nbsp; <u>technology.transfer@nrel.gov</u></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">If to Licensee:</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Comstock IP Holdings LLC</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">117 American Flat Road</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Virginia City, Nevada 89441</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Telephone No.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (303) 275-4435</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">E-mail Contact:&nbsp; &nbsp; <u>legal@comstockinc.com</u></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">If to DOE:</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Brian Lally</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Assistant General Counsel for Technology Transfer &amp; Intellectual Property</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">E-mail Contact:&nbsp; &nbsp; <u>brian.lally@hq.doe.gov</u></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>13.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">All financial obligations due to Alliance shall be sent to:</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">National Renewable Energy Laboratory</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">15013 Denver West Parkway</p>
			</td>
		</tr>
		<tr>
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: auto;">Golden, Colorado 80401</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Attention:&nbsp; &nbsp; Royalty Cashier MS: RSF 041</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">All such payments shall be accompanied by documentation identifying this Agreement, including the License Agreement Number and the names of the Parties. A copy of all financial obligations shall be sent to NREL&#8217;s Technology Transfer Office at the above address in Section 12.1.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>13.3.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Any notice, report or any other communication required or permitted to be given by one Party to the other Party by this Agreement shall be in writing and either: (a) served personally on the other Party; (b) sent by express, registered or certified first-class mail, postage prepaid, addressed to the other Party at its address as indicated above, or to such other address as the addressee shall have previously furnished to the other Party by proper notice; (c) delivered by commercial courier to the other Party; (d) sent by facsimile to the other Party at its facsimile number indicated above or to such other facsimile number as the Party shall have previously furnished to the other Party by proper&nbsp;notice, with machine confirmation of transmission or (e) sent by electronic mail to the other Party with electronic confirmation of receipt.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="15" data-prefix="Page " data-suffix="" style="text-align: right; font-size: 10pt; font-family: Times New Roman;">Page 15</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="width: 100%;">
<div class="hf-row">
<div class="hf-cell" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; margin: 0pt; width: 99.9%; display: inline-block;">NREL License Agreement No. 24-00500</div>
</div>

<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: left; margin: 0pt; width: 99.9%; display: inline-block;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>14.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Non-Abatement of Royalties</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>14.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Alliance and Licensee acknowledge that certain of the Licensed Patent Rights may expire prior to the conclusion of the term of this Agreement. However, Alliance and Licensee agree that the License Fees provided for in Exhibit B shall be uniform and undiminished for as long as any claim of, or other intellectual property right in, any of the Licensed Patent Rights are enforceable except as otherwise provided in this Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>15.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Confidential Information</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>15.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Parties agree that all information, marked by Licensee as &#8220;<b><u>Proprietary</u></b>&#8221;&nbsp;or Alliance as &#8220;<b><u>NREL</u></b><b>&nbsp;</b><b><u>Protected Information</u></b>&#8221;&nbsp;and forwarded to one by the other for the purposes of this Agreement (a) are to be received in strict confidence, (b) are to be used only for the purposes of this Agreement, and (c) are not to be disclosed by the recipient Party, its agents or employees without the prior written consent of the other Party, except to the extent that the recipient Party can establish competent written proof that such information</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>15.1.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">was in the public domain at the time of disclosure;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>15.1.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">later became part of the public domain through: (A) no act or omission of the recipient, its employees, agents, successors or assigns and (B) no breach by a third party with an obligation of confidentiality to the disclosing Party;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>15.1.3.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">was lawfully disclosed to the DOE or recipient Party by a third party having the right to disclose it;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>15.1.4.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">was already known by the DOE or recipient Party at the time of disclosure which can be shown by competent evidence;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>15.1.5.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">was independently developed by the DOE or recipient Party without the utilization of the other Party&#8217;s protected property and information; or</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>15.1.6.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">is required by law or regulation to be disclosed, provided however, that the disclosing Party shall first give the recipient written notice and adequate opportunity to object to such order for disclosure or to request confidential treatment.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>16.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Waivers</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>16.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The failure of Alliance at any time to enforce any provisions of this Agreement or to exercise any right or remedy shall not be construed to be a waiver of such provisions or of such rights or remedy or the right of Alliance thereafter to enforce each and every provision, right or remedy.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>16.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The waiver of a specific breach hereunder may be effectuated only by a written document, signed by the waiving Party, and delivered to the breaching Party. Such formal waiver shall not constitute a waiver of any other breach.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>17.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Entire Agreement and Legal Amendments</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>17.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Parties expressly understand and agree that this instrument contains the entire agreement between the Parties with respect to the subject matter of this Agreement and that all prior representations, warranties, or agreements relating to this subject matter have been merged into this instrument and are thus superseded in totality by this Agreement. This Agreement may be amended only by a written instrument signed by the duly authorized representatives of both of the Parties.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>17.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Parties agree that if any part, term, or provision of this Agreement shall be found illegal or in conflict with any valid controlling law, the validity of the remaining provisions shall not be affected thereby.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>17.3.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In the event the legality of any provision of this Agreement is brought into question because of a decision by a court of competent jurisdiction of any country in which this Agreement applies,&nbsp;Alliance, by written notice to Licensee, may revise the provision in question or may delete it entirely so as to comply with the decision of said court.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="16" data-prefix="Page " data-suffix="" style="text-align: right; font-size: 10pt; font-family: Times New Roman;">Page 16</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="width: 100%;">
<div class="hf-row">
<div class="hf-cell" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; margin: 0pt; width: 99.9%; display: inline-block;">NREL License Agreement No. 24-00500</div>
</div>

<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: left; margin: 0pt; width: 99.9%; display: inline-block;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>18.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Headings</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>18.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The headings for the Sections set forth in this Agreement are strictly for the convenience of the Parties hereto and shall not be used in any way to restrict the meaning or interpretation of the substantive language of this Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>19.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Assignment and Change in Control</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>19.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Licensee acknowledges and agrees that Alliance may transfer this Agreement and all rights, duties and obligations hereunder, to the DOE or a successor management and operating contractor of NREL as may be required under the Prime Contract with DOE.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>19.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Licensee may assign this entire Agreement or any of its rights hereunder, upon the prior written authorization of Alliance, in connection with the sale of all or a material portion of any subsidiary, division, or business unit of Licensee, whether by merger, sale of assets, sale of stock, or otherwise. Licensee is prohibited from assigning to any entity operating, organized, or headquartered in, or majority controlled or owned (directly or indirectly) by an entity in a DOE Country of Risk. Any assignment made without the prior written authorization of Alliance is null and void. Licensee must be in good standing with all terms and conditions of this Agreement, the new assignee must agree in writing to be bound by this Agreement, and Licensee will submit written documentation of such to Alliance prior to the assignment. Prior to any assignment constituting a &#8216;covered transaction under the Committee on Foreign Investment in the United States (&#8220;<b><u>CIFIUS</u></b>&#8221;) rules, Licensee shall submit any required notifications to CIFIUS.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>19.3.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Licensee shall notify Alliance and DOE in writing of any Change in Control within ninety (90) business days of such Change in Control. As stated in Section 10.6, failure to notify Alliance and DOE of a Change in Control will result in automatic termination of this Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>20.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Disputes and Governing Laws</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>20.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">This Agreement, and the rights and liabilities of the Parties with respect to this Agreement and its subject matter, shall be governed by the laws of the State of Colorado, without reference to the principles of conflicts of laws thereof. Any dispute arising out of or relating to this Agreement or its subject matter not settled by the Parties may be resolved only by the courts of the State of Colorado, or if subject matter jurisdiction exists, by the United States federal courts, with venue in the County of Denver (in the case of state court) or in the U.S. District Court for the District of Colorado (in the case of federal court). Each of the Parties hereby consents to the jurisdiction of such courts over it in any action involving any such dispute. Each of the Parties agree not to commence or maintain a legal proceeding involving any such dispute in any forum except a court of the State of Colorado located in Denver County or the United States District Court for the District of Colorado (other than to enforce a judgment obtained in such courts) and agrees not to contest the venue of any action involving any such dispute in the County of Denver or the District of Colorado, as the case may be, nor to assert in any such court the doctrine of forum non conveniens, or the like.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>20.2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">If any provisions of this Agreement are held to be invalid, illegal, or unenforceable in any respect, that invalidity, illegality, or unenforceability will not affect any other provisions of this Agreement. This Agreement will be construed as if the invalid, illegal, or unenforceable revision were never in this Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>20.3.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Alliance will release information concerning this Agreement if required by law.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>21.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Non-Use of Names</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>21.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In publicizing or promoting anything made, used, offered for sale, sold or imported under this Agreement, Licensee, and all Sublicensees, if any, shall not use the name of Alliance, NREL, MIT, or DOE or otherwise refer to any organization related to Alliance, MIT, or DOE, except with the prior written approval of Alliance, MIT, and DOE. By entering into this Agreement, Alliance neither directly nor indirectly endorses any product or service provided, or to be provided, by Licensee&nbsp;whether directly or indirectly related to this Agreement. However, Licensee may state that it licensed from Alliance one or more of the patents and/or patent applications comprising the Licensed Patent Rights, and Alliance may state that it licensed to Licensee one or more of the patents and/or patent applications comprising the Licensed Patent Rights, and may further include (i) Alliance inventor names, (ii) invention titles and summaries, (iii) technology field of use, and (iv) the type and extent of the license, but may not include terms and conditions of this Agreement unless such disclosure is required by law, rule or regulation.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="17" data-prefix="Page " data-suffix="" style="text-align: right; font-size: 10pt; font-family: Times New Roman;">Page 17</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="width: 100%;">
<div class="hf-row">
<div class="hf-cell" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; margin: 0pt; width: 99.9%; display: inline-block;">NREL License Agreement No. 24-00500</div>
</div>

<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: left; margin: 0pt; width: 99.9%; display: inline-block;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>22.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Counterparts</b></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>22.1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">This Agreement may be executed in separate counterparts, each of which so executed and delivered shall constitute an original, but all such counterparts shall together constitute one and the same instrument. Any such counterpart may comprise one or more duplicates or duplicate signature pages, any of which may be executed by less than all of the Parties, provided that each Party executes at least one such duplicate or duplicate signature page. The Parties stipulate that a photo static copy of an executed original will be admissible in evidence for all purposes in any proceeding as between the Parties.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="18" data-prefix="Page " data-suffix="" style="text-align: right; font-size: 10pt; font-family: Times New Roman;">Page 18</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="width: 100%;">
<div class="hf-row">
<div class="hf-cell" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; margin: 0pt; width: 99.9%; display: inline-block;">NREL License Agreement No. 24-00500</div>
</div>

<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: left; margin: 0pt; width: 99.9%; display: inline-block;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>IN WITNESS WHEREOF </b>the Parties have duly executed, or caused their duly authorized representative, to execute this License Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>For Alliance:</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>ALLIANCE FOR SUSTAINABLE ENERGY, LLC</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 45pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">By:</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><u>/s/ Anne Miller&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</u></p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 45pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Name:</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Anne Miller</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 45pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Title:</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Director, Technology Transfer Office</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>For Licensee:</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>COMSTOCK IP HOLDINGS LLC</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 45pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">By:</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><u>/s/ Kevin Kreisler&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</u></p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 45pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Name:</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Kevin Kreisler</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 45pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Title:</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Chief Technology Officer</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">[SIGNATURE PAGE TO LICENSE AGREEMENT]</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="19" data-prefix="Page " data-suffix="" style="text-align: right; font-size: 10pt; font-family: Times New Roman;">Page 19</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="width: 100%;">
<div class="hf-row">
<div class="hf-cell" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; margin: 0pt; width: 99.9%; display: inline-block;">NREL License Agreement No. 24-00500</div>
</div>

<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: left; margin: 0pt; width: 99.9%; display: inline-block;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>EXHIBIT A</u></b><b> </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>INTELLECTUAL PROPERTY</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>[Information has been omitted from the filed version of the exhibit]</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="20" data-prefix="Page " data-suffix="" style="text-align: right; font-size: 10pt; font-family: Times New Roman;">Page 20</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="width: 100%;">
<div class="hf-row">
<div class="hf-cell" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; margin: 0pt; width: 99.9%; display: inline-block;">NREL License Agreement No. 24-00500</div>
</div>

<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: left; margin: 0pt; width: 99.9%; display: inline-block;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>EXHIBIT B</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>LICENSE FEES</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>[Information has been omitted from the filed version of the exhibit]</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="21" data-prefix="Page " data-suffix="" style="text-align: right; font-size: 10pt; font-family: Times New Roman;">Page 21</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="width: 100%;">
<div class="hf-row">
<div class="hf-cell" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; margin: 0pt; width: 99.9%; display: inline-block;">NREL License Agreement No. 24-00500</div>
</div>

<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: left; margin: 0pt; width: 99.9%; display: inline-block;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>EXHIBIT C</u></b><b> </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>COMMERCIALIZATION MILESTONES</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>[Information has been omitted from the filed version of the exhibit]</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="22" data-prefix="Page " data-suffix="" style="text-align: right; font-size: 10pt; font-family: Times New Roman;">Page 22</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="width: 100%;">
<div class="hf-row">
<div class="hf-cell" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; margin: 0pt; width: 99.9%; display: inline-block;">NREL License Agreement No. 24-00500</div>
</div>

<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: left; margin: 0pt; width: 99.9%; display: inline-block;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>EXHIBIT D</u></b><b> </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>SAMPLE REPORT FORM</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>[Information has been omitted from the filed version of the exhibit]</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="23" data-prefix="Page " data-suffix="" style="text-align: right; font-size: 10pt; font-family: Times New Roman;">Page 23</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex_729047.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_729047.htm</title>

	<!-- Generated by ThunderDome Portal - 10/1/2024 10:52:17 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 99.1</b></font></p>

<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<p style="margin: 0px 0pt; text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font><img alt="logo.jpg" src="logo.jpg"></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Comstock Executes Exclusive License and Cooperative Research and Development Agreement with Department of Energy</b>&#8217;<b>s National Renewable Energy Laboratory</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><i>World Class Innovation Team Set Sights on 100% Renewable Sustainable Aviation Fuel and Fossil Parity</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>VIRGINIA CITY, NEVADA, October 2, 2024</b> &#8211; Comstock Inc. (NYSE: LODE) (&#8220;Comstock&#8221; and the &#8220;Company&#8221;) today announced the execution by Comstock&#8217;s wholly-owned subsidiary, Comstock IP Holdings LLC, of an Exclusive License Agreement (&#8220;ELA&#8221;) and Cooperative Research and Development Agreement (&#8220;CRADA&#8221;) with Alliance for Sustainable Energy LLC (&#8220;Alliance&#8221;), the managing and operating contractor of the U.S. Department of Energy&#8217;s (&#8220;DOE&#8221;) National Renewable Energy Laboratory (&#8220;NREL&#8221;), involving technologies developed by NREL and the Massachusetts Institute of Technology (&#8220;MIT&#8221;) for conversion of lignocellulosic biomass into aromatic sustainable aviation fuel (&#8220;SAF&#8221;). NREL and MIT are separately party to an Inter-Institutional Agreement that appointed NREL the exclusive right to license NREL&#8217;s and MIT&#8217;s joint intellectual properties, and Comstock IP Holdings previously granted Comstock Fuels Corporation the master exclusive rights for commercialization of its existing and new renewable fuels technologies.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Comstock</i></b>&#8217;<b><i>s Existing Process</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Comstock Fuels offers advanced lignocellulosic biomass refining solutions that produce market-leading yields of cellulosic ethanol, gasoline, renewable diesel, SAF, and other renewable fuels at extremely low carbon intensities. The Comstock Fuels process generally involves: (1) solvolytic digestion and fractionation of lignocellulosic biomass, (2) bioconversion of cellulose into Cellulosic Ethanol, (3) esterification of lignin and other derivatives into Bioleum Oil, (4) hydrodeoxygenation of Bioleum Oil into Hydrodeoxygenated Bioleum Oil (&#8220;HBO&#8221;), (5) refining of the resulting intermediates into ASTM compliant renewable fuels, and (6) gas-to-liquids emissions capture and fuel conversion. The first five of these processes are proven to produce up to 125 gallons of renewable fuel per dry metric ton of feedstock (on a gasoline gallon equivalent basis, or GGE), depending on feedstock, lignin content, site conditions, and other process parameters, with extremely low carbon intensity scores of 15. The sixth step has the potential to increase bulk biomass conversion yields even further, to more than 140 GGE and more than 70% of the theoretical maximum yield from most forms of woody biomass.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Integrated Process</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Comstock IP Holdings is focused on continuously improving the proven performance and operations of Comstock Fuel&#8217;s commercial refining solutions, including by increasing feedstock diversity, bulk conversion yields, and product quality for use in SAF while decreasing total variable costs.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The technologies covered by the NREL license have the proven potential to contribute to each of those objectives, including by depolymerizing and stabilizing intermediates, by reforming feedstock derived water to decrease reliance on fossil hydrogen, and by removing oxygen in a way that favors high concentrations of aromatic hydrocarbons for use in SAF.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">David Winsness, President of Comstock Fuels, said, &#8220;Our existing commercial process unlocks and converts wasted, unused, and purpose grown woody biomass into renewable fuels at extraordinary yields and carbon intensities, essentially creating an endless oilwell hidden in plain sight. Our planned commercial facilities have been designed to tap into that oilwell to produce an array of intermediates and fuels. However, further developing and integrating the NREL technologies into our process could give us the remarkable additional ability to maximize aromatic content and quality specifically for high value use in addressing the recent global surge in demand for SAF.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>World Class Team</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The terms of the CRADA involve a three-year scope of work to jointly develop an integrated process based on Comstock&#8217;s existing process and the NREL technologies for the solvocatalytic refining of woody biomass into aromatic SAF and other renewable fuels. Comstock will fund the research and contribute staff, equipment, and use of its pilot facility in Wisconsin. The joint work will be supported by a world class team, including Gregg Beckham, David Brandner, Mickey Stone, and Michelle Reed of NREL, Yuriy Rom&#225;n-Leshkov, MIT&#8217;s Robert T. Haslam Professor in Chemical Engineering, and Joshua Heyne, Director of the Bioproducts, Sciences, and Engineering Lab at Washington State University. The CRADA is anticipated to culminate in construction of a pre-commercial pilot system to validate the requirements needed to rapidly scale-up the resulting process into Comstock&#8217;s already planned 50,000 metric ton per year commercial demonstration facility.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Gregg Beckham, Senior Research Fellow for NREL, said, &#8220;An integrated process based on Comstock&#8217;s and NREL&#8217;s technologies would have remarkable potential in decarbonizing liquid fuels. Comstock&#8217;s established market leadership and commercial scale-up plans for its existing process provide an exciting opportunity to accelerate commercialization of NREL&#8217;s technology. Our respective teams from NREL and MIT are delighted to work with Comstock to scale-up this technology for low-carbon fuels and products.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#8220;Comstock&#8217;s mission is to enable systemic decarbonization, starting with transportation,&#8221; said Kevin Kreisler, Comstock&#8217;s chief technology officer. &#8220;Our plan to do so involves developing and commercializing highly profitable new processes that bootstrap the Earth&#8217;s natural carbon cycle while enabling stakeholders at all levels of the mobility supply chain to produce and use enough renewable fuels to decarbonize at globally meaningful scales. Our existing commercial process launches that effort, but we believe that we can maximize the breadth and rate of global market adoption with continued innovation to produce the world&#8217;s first 100% renewable SAF at costs that approach parity with fossil fuels. We believe that feat to be achievable by integrating Comstock&#8217;s and NREL&#8217;s technologies, and we&#8217;re excited to get to work.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The ELA provides Comstock IP Holdings with the exclusive worldwide right to use the NREL technologies in the processing and conversion of seed plants to renewable fuels and renewable fuel feedstocks, including native, hybrid, and transgenic phenotypes, and derivatives thereof, excluding switchgrass, big bluestem, miscanthus, and the leaves, stalks, and husks produced during the harvesting of corn, subject to limited geographic restrictions, in exchange for royalty and other fees linked to sales of licensed products and sublicensing.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">NREL&#8217;s and MIT&#8217;s prior work on the NREL technologies was initially funded by the Center for Bioenergy Innovation, a DOE Research Center supported by the Office of Biological and Environmental Research in the DOE Office of Science, and the DOE Bioenergy Technologies Office on the Lignin Conversion to Sustainable Aviation Fuel Blendstocks project. More information on the technologies is available online in the articles titled <u><i>Catalytic Process With Lignin Could Enable 100% Sustainable Aviation Fuel</i></u>, <u><i>Making Aviation Fuel from Biomass</i></u>, and <u><i>Continuous Hydrodeoxygenation of Lignin to Jet-Range Aromatic Hydrocarbons</i></u><i>.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Technology Readiness Level</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Comstock uses the technology readiness scale to estimate the readiness of technology from conception to commercialization, iterating sequentially as follows: (i) TRL 1 (basic principles observed and reported); (ii) TRL 2 (technology concept and application formulated); (iii) TRL 3 (analytical and experimental proof of concept); (iv) TRL 4 (validation in laboratory environment); (v) TRL 5 (pre-pilot scale validation in relevant environment); (vi) TRL 6 (pilot prototype demonstration in relevant environment); (vii) TRL 7 (scaled-up commercial prototype in operational environment); (viii) TRL 8 (commercial system demonstration); (ix) TRL 9 (commercial maturity).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The NREL technologies covered by the Comstock license have been validated at TRL 4. The scope of work under the CRADA involves rapid validation of an integrated TRL 3 process based on Comstock&#8217;s and NREL&#8217;s technologies, followed by construction of a TRL 6 pre-commercial pilot system. Once complete, a modular TRL 7 scale-up of the integrated process would be added to Comstock&#8217;s recently announced 50,000 metric ton per year demonstration facility to provide the data required for scale-up in Comstock&#8217;s planned 1,000,000 metric ton per year commercial facilities at TRL 8.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>About Comstock Inc.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Comstock Inc. (NYSE: LODE) commercializes innovative technologies that contribute to global decarbonization and the clean energy transition by efficiently converting under-utilized natural resources, primarily, woody biomass into low-carbon renewable fuels, end-of-life metal extraction and renewal, and generative AI-enabled advanced materials synthesis and mineral discovery for sustainable mining. To learn more, please visit <u>www.comstock.inc</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Comstock Social Media Policy</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Comstock Inc. has used, and intends to continue using, its <u>investor relations</u> link and main website at <u>www.comstock.inc</u> in addition to its <u>Twitter</u>, <u>LinkedIn</u> and <u>YouTube</u> accounts, as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">CONTACTS:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>For investor inquiries: </b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">RB Milestone Group LLC</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Tel (203) 487-2759</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u><b>ir@comstockinc.com</b><b> </b></u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>For media inquiries or questions: </b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Comstock Inc., Zach Spencer</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Tel (775) 847-7532</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u><b>questions@comstockinc.com</b></u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Forward Looking Statements</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">This press release and any related calls or discussions may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, are forward-looking statements. The words &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;plan,&#8221; &#8220;should,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;potential&#8221; and similar expressions identify forward-looking statements but are not the exclusive means of doing so. Forward-looking statements include statements about matters such as: future market conditions; future explorations or acquisitions; future changes in our research, development and exploration activities; future financial, natural, and social gains; future prices and sales of, and demand for, our products and services; land entitlements and uses; permits; production capacity and operations; operating and overhead costs; future capital expenditures and their impact on us; operational and management changes (including changes in the Board of Directors); changes in business strategies, planning and tactics; future employment and contributions of personnel, including consultants; future land and asset sales; investments, acquisitions, joint ventures, strategic alliances, business combinations, operational, tax, financial and restructuring initiatives, including the nature, timing and accounting for restructuring charges, derivative assets and liabilities and the impact thereof; contingencies; litigation, administrative or arbitration proceedings; environmental compliance and changes in the regulatory environment; offerings, limitations on sales or offering of equity or debt securities, including asset sales and associated costs; business opportunities, growth rates, future working capital, needs, revenues, variable costs, throughput rates, operating expenses, debt levels, cash flows, margins, taxes and earnings. These statements are based on assumptions and assessments made by our management in light of their experience and their perception of historical and current trends, current conditions, possible future developments and other factors they believe to be appropriate. Forward-looking statements are not guarantees, representations or warranties and are subject to risks and uncertainties, many of which are unforeseeable and beyond our control and could cause actual results, developments, and business decisions to differ materially from those contemplated by such forward-looking statements. Some of those risks and uncertainties include the risk factors set forth in our filings with the SEC and the following: adverse effects of climate changes or natural disasters; adverse effects of global or regional pandemic disease spread or other crises; global economic and capital market uncertainties; the speculative nature of gold or mineral exploration, and lithium, nickel and cobalt recycling, including risks of diminishing quantities or grades of qualified resources; operational or technical difficulties in connection with exploration, metal recycling, processing or mining activities; costs, hazards and uncertainties associated with precious and other metal based activities, including environmentally friendly and economically enhancing clean mining and processing technologies, precious metal exploration, resource development, economic feasibility assessment and cash generating mineral production; costs, hazards and uncertainties associated with metal recycling, processing or mining activities; contests over our title to properties; potential dilution to our stockholders from our stock issuances, recapitalization and balance sheet restructuring activities; potential inability to comply with applicable government regulations or law; adoption of or changes in legislation or regulations adversely affecting our businesses; permitting constraints or delays; challenges to, or potential inability to, achieve the benefits of business opportunities that may be presented to, or pursued by, us, including those involving battery technology and efficacy, quantum computing and generative artificial intelligence supported advanced materials development, development of cellulosic technology in bio-fuels and related material production; commercialization of cellulosic technology in bio-fuels and generative artificial intelligence development services; ability to successfully identify, finance, complete and integrate acquisitions, joint ventures, strategic alliances, business combinations, asset sales, and investments that we may be party to in the future; changes in the United States or other monetary or fiscal policies or regulations; interruptions in our production capabilities due to capital constraints; equipment failures; fluctuation of prices for gold or certain other commodities (such as silver, zinc, lithium, nickel, cobalt, cyanide, water, diesel, gasoline and alternative fuels and electricity); changes in generally accepted accounting principles; adverse effects of war, mass shooting, terrorism and geopolitical events; potential inability to implement our business strategies; potential inability to grow revenues; potential inability to attract and retain key personnel; interruptions in delivery of critical supplies, equipment and raw materials due to credit or other limitations imposed by vendors; assertion of claims, lawsuits and proceedings against us; potential inability to satisfy debt and lease obligations; potential inability to maintain an effective system of internal controls over financial reporting; potential inability or failure to timely file periodic reports with the Securities and Exchange Commission; potential inability to list our securities on any securities exchange or market or maintain the listing of our securities; and work stoppages or other labor difficulties. Occurrence of such events or circumstances could have a material adverse effect on our business, financial condition, results of operations or cash flows, or the market price of our securities. All subsequent written and oral forward-looking statements by or attributable to us or persons acting on our behalf are expressly qualified in their entirety by these factors. Except as may be required by securities or other law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Neither this press release nor any related calls or discussions constitutes an offer to sell, the solicitation of an offer to buy or a recommendation with respect to any securities of the Company, the fund, or any other issuer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>lode-20241001.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 10/2/2024 3:12:36 AM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:lode="http://www.lode.com/20241001" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.lode.com/20241001">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lode-20241001_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lode-20241001_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lode-20241001_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.lode.com/20241001/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="lode_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>lode-20241001_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 10/2/2024 3:12:37 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.lode.com/20241001/role/statement-document-and-entity-information" xlink:href="lode-20241001.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.lode.com/20241001/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>lode-20241001_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 10/2/2024 3:12:37 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>lode-20241001_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 10/2/2024 3:12:37 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.lode.com/20241001/role/statement-document-and-entity-information" xlink:href="lode-20241001.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.lode.com/20241001/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>logo.jpg
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  H ) # 2(  A$! Q$!_\0
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M5GM$:1$GD\@%00.0JJJY[[2:_03XTQO-\'/'<<:-)(V@WZJJ@DDFWDP !U-
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MZOQ)_9<^**?!7X3>+--OKC7/BYX&9KZXAN[@W$UR))O.\H.Q^=HB NW.&&X
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..1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45493709002192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Oct. 01, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">COMSTOCK INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Oct.  01,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">001-35200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">65-0955118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">117 American Flat Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Virginia City<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">89440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">847-5272<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LODE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0001120970<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( *XU0ED'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " "N-4)9,>CT[.\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M3L,P#(9?!>7>.LT&2%'7"X@32$A, G&+'&^+:-HH,6KW]J1EZX3@ 3C&_O/Y
ML^0:@\8^TG/L T5VE*Y&WW9)8]B( W/0  D/Y$TJ<Z++S5T?O>'\C'L(!C_,
MGD!)>0.>V%C#!B9@$1:B:&J+&B,9[N,);W'!A\_8SC"+0"UYZCA!558@FFEB
M.(YM#1? !&.*/GT7R"[$N?HG=NZ ."7'Y);4, SEL)IS>8<*WIX>7^9U"]<E
M-AU2_I6<YF.@C3A/?EW=W6\?1*.D6A>5+*3:5E*OK[6Z?9]<?_A=A'UOW<[]
M8^.S8%/#K[MHO@!02P,$%     @ KC5"69E<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MP %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ KC5"69>*NQS     $P(
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M,AF**I9P6B#BR2!M:59]L$].M.=Y%S?W1:[-XPFNWPQP>'3^ 5!+ P04
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MYHOA/UY_ 5!+ 0(4 Q0    ( *XU0ED'04UB@0   +$    0
M  "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ KC5"63'H].SO
M    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L!
M A0#%     @ KC5"69E<G",0!@  G"<  !,              ( !S0$  'AL
M+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " "N-4)9!( ;Y3\$  "7$
M&               @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L!
M A0#%     @ KC5"69^@&_"Q @  X@P   T              ( !@PP  'AL
M+W-T>6QE<RYX;6Q02P$"% ,4    " "N-4)9EXJ[',     3 @  "P
M        @ %?#P  7W)E;',O+G)E;'-02P$"% ,4    " "N-4)9.JJBYT !
M   \ @  #P              @ %($   >&PO=V]R:V)O;VLN>&UL4$L! A0#
M%     @ KC5"620>FZ*M    ^ $  !H              ( !M1$  'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ KC5"6660>9(9 0
MSP,  !,              ( !FA(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
2      D "0 ^ @  Y!,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="lode20241001_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lode.com/20241001/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>lode-20241001.xsd</File>
    <File>lode-20241001_def.xml</File>
    <File>lode-20241001_lab.xml</File>
    <File>lode-20241001_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="lode20241001_8k.htm">lode20241001_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "lode20241001_8k.htm": {
   "nsprefix": "lode",
   "nsuri": "http://www.lode.com/20241001",
   "dts": {
    "schema": {
     "local": [
      "lode-20241001.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "lode-20241001_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "lode-20241001_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lode-20241001_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "lode20241001_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 26,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.lode.com/20241001/role/statement-document-and-entity-information",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "d20248K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lode20241001_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d20248K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lode20241001_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.lode.com/20241001/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001437749-24-030393-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-24-030393-xbrl.zip
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M,LMA#W*B66CEM'\Y/#OMGXASZ/ 7KV=QTG]]=MZ_/#O_]99E1=:^-%FXPDC
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MSO=84X8*LA#5D=+<5/?\RXK8-.G.J-HMNC1U,BZ:PE&M C2==L^FN=A-QLW
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M%=S[&$_5T5LBKSE$(E=752)9(J$88,].!^\1DI&4+FYNX;.HI>@+7:,A093
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MVR"W7ESB/L3Y/_T6<?Y/0YQ_B/-?_SC_(!]\&?E@;5%[) .8>/%.6<"&C%-
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MY)XM(TZ5S-M)_ZF@>X1!2/BEJYM>WU4"!"65RV;XH<&=$X.DK/L<OT&47TZ
M+__OA[V]O3W\#Z]CO%=U;.6T__W8_2;3%-,#R:LKS$%2MFM1M2HB^(&3+:1I
M+?$AT\+K;:YNR]F-)1(XKS:0*K(=$MA@:@IKQU!9E3LN X_3L'38O.T.@8 J
MV4#/+^%W>&"49S)F#"Y=+R91TO+SC<BQ_UH67+IDG)<T3>@'.FJTXU4KI7N"
M107,V3"MIFXK,;VRFYM[WW'T1M)XDS"9,UP @Z?*&2PS^?(=#+R>FDDZ0_M$
ML;3E\K3\$HN=8ERX(C;VBEA/LW:+JUENX:1'H@I;WU/A;U1"U(1TUP19S;P2
MHT[LLR\:H6^I+NK-W7$M&I+-D(O+HJ1:4RAJ;^T_-@5L1@I8B/)#[R)@]5?*
M%55Q8PS$N;G$N9ZVZA:U.#FH^ PI8*06F4GQ ,*5MKGR<TK: BI0K>(WPE1-
M\OHMN>TGL.<L]2M%1Z-SL\B($IRB&BVV7-Y2OE%/WJQGDRPZA<]6*@A4GWT[
M0VTK0N/'E5'B[1M&]!CQ9,8HAFT! UDHF=NI:>@_QK(-J/+6%?K,K[$J(AB1
MK=4T*HRM M8GL)7-92OKF3,;BT.XV'8N],&&W\*KV&WSPKPWEF#ZA1D OF\R
MJ=8<IY%*SJ^!XIM3VP515IE"6]WVQ"2[QO# 7CT '"Q:_D!0B*G,L,[C'9[,
M"-@AB.Q:YHL.SD:V,SB=R$A)_B@X:WA>%R7G!HB#8%>DG5&U4%-*)5'+Q:.
M(=&P6L7N8)DTMW*M2$Q!6S+KQAC;6&;KQ3[N!0[NX)O@X X"#B[@X (.[GXG
M^7B^E@(!%='P*E'CQ6?+GF6%R?UVZ7+-]IVS)Z!+-EC\?;ZN@;[5JU:Q4I3[
M^+S#MK?JD^J"JQMC4;U;7.$MG[#Z%"55@;IFOMP=*=6Y H'5E$Q&@1D!"R"2
M@G)9.2<K*?TJE<;L=E-VY=H]PP65*8N(J=G&!9=WQ5LK2+?J'']4:N9EOK(.
M];H%;UP]SF8"#W[L\O1.IRY?9%%=7:F"[>54SI 4#8)JU/8Z]K(7;ED*D)O9
M=T+=< GL9AV[QB*9U[$.'W8=MTK-D\; V6+5IYE5:SA7K5E0DWJVH+JP2T;*
M*$.0#+H0R#KI%@ZFHL@QPUT0F,+4C$#4B:R]UVZG0.!,5&13?&N:%'W3A@E8
M] *I&FEL?QW!8G:6H'6Y 'NT5+I4T\)XLJV1"(]1CN][FIHQZ.3D,2G1'R49
M5$*I!-'L8@TY,<RS,#_49I[@ PD7@G\AK&G$>04J&A"&NP)8ZMG%FX W >X+
ME<]5*-NRP6=[/:&T<+;/TJL,#W7K>+.<TRQNVU%-UD)16V^[[U?)0E&45R81
M&MG/R*1.11G&8X.$.,([M;-2[QS%%^[#^#JP2Y>6'BL.(TB"T0F14U'P(L,"
MPE3O3"[H^*.14G+?DH"&:"'<>KAGW(<\+I =E)Z5C#$PG?OPM$#V&TOVZXG\
M K(_KM,XOY>+&RXWOY1YK"*T116,.:4"X.,*@;CI4@LD#9M*,,9+AM@9/=;L
M);-P7N"<!LN)Y)DJ= K*?&%%6I N2^62&5K#O)'($2-6%!4G?_>&249A!*1'
MLJCKA2OQ6J8?\VI61@L88TS,9?_YTV=+VHX#;[DJW@B/DB-@'(BZSJ9<U!V>
MM$B'>D!+( ="L,6ZB'+%VA&\2F@JJJH-W2! SC"ITGD'#-+M)2Z5R3F)DVE4
MT%JP#AFKQA@<=-M\MN4<7:Y$*BW.*??G#5A:C9<=DS,G<W5[_/:7@@!<[9TJ
MIW'6*"A?EPA,<G.9Y'IBGX!)=ADU/=98@^@IUW>/84X4X=%$-C7=G%C#AIKS
M+2H>0+8NV^7AYHFLR5?AY?"G* 0&X+/MR%HL+.P1M/*LRB.#(:TY(0%O9[DF
MY*,5K8IE )9<,"2B2EB0(O!L% %=U'@L<@/G"!T^-*#0^GLOCL!):UW3"]SA
MOKDZ]O?6D^A'0/3YE&K.-3 ! YDG"W%9HZ*"<V.#[S0XW6OKW< S[%UB%_5U
MHNB,^\B_&^NY6F,YU7>S06<<E=!Z;?")RE<4XI >.^JU43=.\E1._2<+0B&2
MC*-+;W*L(+90I>3:0--ZC<,)U\H&$^C:6IO/K=9I;QLC:!VBOOZ>=&F/?@>L
M';XG;-LJ_;5T+;4(CQJ.9%4HXW1B7>ZW*M;D%D(!,F%/&@FW+?"]D4&YED!M
MQ$NS=(=+W+!E$8>&;XRU8DH&R0\.(;KB6D]1I&5='<?$*3,*;P5:KZ,]@S\L
M.? 6(\4,O/B&GHV]HM"?T +X9&\;EB4!KB)S-@62 .Y9 DF6-<NPA=K^P=Y+
M.'BP?]X^X3;A*:3?]U]N@^X]MM%VT+:5U[TW[CH=,_,<A7UT J.Y R%#54G&
M"0[_!4HO%KT&4!/-!@:LF;&/%OZE739G9BI+WL8<_9WT554X7ZCG[6MP>'LG
M[#_?W8=A)MDU3;7M)^\Z&)Z7T+4"U$O#3I?B IU9J;;4-O:I)[)KSSYMM!CV
M.<>5NCE9 '?I*T=-JU9M :^=V!8Z=HP5![U@=[\ 6[L>U++%!3LI$QX$[0J>
M?"_&#ZL.QX1X=?'6&/4BK_&%AC5^R?F[JM94N!PW^')<6W>5IX'Q<<^*H@:D
M^8;KRRX1L[X(<6*8K2"BF!*ZW*2)^I<QW7\N^$6G<QA*3/D:JM3)EV1RZ=F4
M"3!@.'J5+B86([?:_]5S23@8M1)(<8-)<6U=2$LFD15>(ZP82GZ# IXJQ@O?
M1,GW*!"+O?H/=A_U?&D"Y(!:>^RAZ@B4,S#"P8U^&S*TJD^(;RI4(Y] [8VQ
MELJ6VW=9RFU8;U=*TQW64>QT6:_V9Q^(?X.)?XU=(\U[>#CE;&'B,I=I,59Y
MAY^DMX(*>Z25^"&6*RF,[VF4C4L$))+8;CILI6YP@$9KMG*-F))R. 8J>$>>
M3';+N+IX'"JF.-.<+&S]9/KQ&OG)#$=8EK5BR5:P-9>R[T4 U\-O$L#U, 1P
MA0"N$, 5;G9SLZ]G3HF.F[T?N>+.'IC'WNVUP<NS;W5Z=YH*=WW#^\@M<ZMS
MU5>\C8$_<H9#LJ21\&!P2%W!!7A3 R,D1"?H\7BC>V ERN3IE)%<819&>.#0
M)80A_$*6,"ZJ85@CKQ46AB7IGD :F:^E/%RO:SZ0^A<E]?7,\]!!ZC5 LHO"
M+< :$Q[7E&%S+Y64=PDTZ!$FV<6D>J1*N[BN>994:0GC3!8FFHVZ'-5=-K&-
M-ZL RYIY@X^,,-I+H1) C@V2^0NVZUVAR&XZ[7&258,E=TXOR@H,:L6.^\9+
M/NJT>E!>8EUFF*IO*C^2E=\D W9XIU:VB-9;K14QHZ@7!,<Q,8F5(Z6Q_C6V
MF<,.PA2W3/N)_J@03.J_"+/*=&J4$S8QVO[MBD0+4^Z;C9=S]J81OIU'M6@T
MR)P.UA '&B_GMT &B;X4$'HPO[:*K:,FA;. MI7GQK;2:X-U[591V)W!(L!8
M$_U[I6.7C@C:=8Y(\D$IY%6<T-OI9*A19NBMJ1"@;XYAX,P;S)F?W0?.W PU
M66++-S)+Z]!G%[]/=R:Y7M'*KN?YOSW^;=BMB9RIWWE!*<"6 X":CM(>)2QU
MZ:Q-,GMXJ9J-\PQY)4J.%)KC):)%4TJ]"G6.+I(E,7Y(<99K(/>L K$P6\B$
M7-Q>0YZ/'46WBD=HXA&L$[]L6+ #L]A49K&FV3DP7X$M87#F9: %SM'MF_E
M*/4;\_LUW9/B&I2Z(N/, "V(N%6CF#/X2E,G5H-X2@?A]:@[=+^F+()Y$W&(
MC5YG?0<N:6%!'KV:$?1:<(V>LPDS!V)++Z8R,,'P:0$,T69<L)&"V34NK)U4
M8!#W#JB^ID#>T2L#?R7P@TF'1PB\ %(/5YHYV6MZMCM3\%@[Y'MK4>B^W4[5
M,B"6ZH* GC_GG#7DYJNC%"G'O(V@ZC8K^O62R/L8E8U:4IA(A;V!=1Z;(%4&
M$@027%L8.F=B0'KQE5'X7YVCM281DR_B=M&2D3L[0GW2!8FLG:VYJ&4_51.7
M^)CYVFJ+3EV^(GCT*L.0\U)R7 CS@:+*YQA;TA \4::D&E+M$@\,4W*5.;S4
MM Y;VYK+&(@BX8)>8TZ-A-FO3:P,EEDJ9-)(>NMER-Y"E"X(IJ*!);^@$3?7
MR8+*X0E+$/0!'G=+T0:>&XD7ITF!F)D+K''J?VTZ(^\(61Q]#",AG#W!V5;>
M<,&F)OV3U%ZP^4M7-*J5I?=%X(E_DB>N:W%8XHGK*9AT4:.RR;+G.L.:;$A5
MJ8O$[HR-ZXACH3S0NJ1Z@5@B+M=7!$7V\F][_/%E()Y-)I[U%"FZB:=1F G3
M:,)%8?SP"?Z-T,)TG%186(;$ ;@P"0X,GP88- .7;2"'C2:']8QE^4+D<)SE
M"EIVM-!S+A\.UT-MU,+9;;D]RFY06VDI^U*CXRKU*GQB>Q.5Q('*-IK*UC-,
MI9O*IO [ZY*+.E?-N=5C+DEF ]6Q;*8J@XN7%!N@'E,PMH8>$/J-GD9BH^A2
M#R1CRGX0[)WK6-K<SS4(GAR<O4!CFTQCZQD-PL@=2V>MM'-=T=TP5>=A["90
M?DMV&H?,547ERDQEP8;%*6]4,AO;?%>VEG;+9%-T]-]RA&(#]3"/V<:S"$;=
M#3;JKJ?(B;@B+UB*_8>-B&F7-9(+N)N< WX*29T:^(X+E3)O4%EZ\P*+E.VT
M$QB>V;/9+$WV H8@XLV+H=24:KZ:4FW[>0TJK*]++"2-KQ>[XHP!X@U3;@N;
M$%=8K8]Q/TMP;A<V1L5\N82 RW#)$VC@4?TD#2&Q?> '#7ZPGL*Q\R_(I,4%
MQJ!N,O#%7-J%<:O8>GI9[4N9*'&CQ^<%QW2#=".VL JGNXJW>^)A3\!/3WOB
M64\\[\%\X+]]^.\Q_/<$_H-?]I\SPSG86R\*NQ>AE(^^22CEHQ!*&4(I0RCE
M/<?=K:<7 T9^C.E_Q#OYFZIRU3F)[_IB^HX/Y_J)?NOJR3[-*!(6\P[Z.#;?
M:,EEU'WTC:GE@(AI6W"N!:7K1,\Y#%Z,7\2-!(^M1S%S(?R&Z;F@8:]@_=C5
M?K/1Q#F:71F0%S$*]DT6]\R'>DJ%'>55G8K<U("/%IQ!,1OWEH!%>94P@/R*
ME%%HAWPO1#0=34H*;YYDN>8H8T8 C#7Z5V(LXU>:.)@K+_*N*/.*7Z8*V78H
M8YW#6T4)JPP?D@QGI:"%R>^5_(C!,U&D8V[-3)SVA:Q7H**J*8T 1,$<AE-
M&]<RQYF,@*Q)2]98EBYGN1Y^T!DT5<A15LHKRH\XEP7]@M7PU%1'/0$]HPD
MKEYL",:MS<ND1&,  &^_FH[@Z&6*%\L<,-J.6"6(_,=#U'B%RWE'.@>UGU/!
M%ZA9D"#&YCDX)UTGU1TJA%Y6F$^^3N$H)$'7*.L:PB<\J[P)21CK<:DH8/5Q
M.V#5!B=02.0NR#XEON. 9-3\*$-+1ME0E!H.-!M+0*>=TL4!4=)]P>V^\ ^<
M3V5__O!A E4,53]$JP>7.#_7Q<?>GSV6A*V#W:P2BB+%>74SD,_C&&N>,.<[
MODR_CXL&+\DUM9:.X)8LM2V>\=X$& 5Y;Y/EO8=K*N_U3>H&>YHY;*^HKU$X
M#\#<B_H.=3%%A;GDB@#9_<K'_M;G.H_8K0LE[KHWMQW'!Z^&8]^O$@[(GST@
M^WO/OM[.?S;[ ;51FGSDYZ!H7-,"#E*57X'4!T)Q+D%I6?#R?N6![3_>VW\H
MCE2*65)^452N-_]X+1<KCN0?W:!G^]_U_KS)$CB*"!E,8#?B3#S;>[2WOUEK
MT"\I$T66ON 1BCO_0^7>8.7@.#L_^1FI2]_3"GXQGX&_%0]>7:I$S299JM#<
MW[E(6P_W'FZ+@Z>/=QX]>OCX>UJ2O_Y0'<NHT/ VK4[WP>+E>?CLT<[31\^?
M;];R#':F4B>$5)91V5J?GZI7I:.L78N[^.\T5\GN53;G4+4@. 3)<EFRM+:D
M(%E^95SL]W] #K-I46;11S%\+]Z"V$/IX$Y.#K\PX[UWZ[:__U3TI_!K)%-Q
MG,@27I=Q6+6;5^UGC7UI*0X)J'BJYC*6XMGS1X^^M'1][Y:N0[!<]?__6A'S
MWJWL;5)7HJYD\M^1890ZC7;A[R!N!7%KE;AU=#8(DE:0M%IGXS5NDCC!M.V!
M(]]B>S(5[4OQ1J64@Q[=\(5**)"HR[[T=SD%9CU,2SBH*BHK>.4]%=(IPV+_
MR>MOA.=V-\%S^]^3WW?C3 5S0_#?KB?L%/VWW=E1,4^I']OD/+H%%[$(%WJX
MT/^H%R]</E_4X?AUUV:5+S#LY^=X#<\IF_1"',IBHF&KWUV\$.<7QV)OI>$G
M,-:-U:+[E&,RFM0EYVM\582(7YEJ3ML39Q&#;+FN"JXHC(4!QNU:E;9>/:*R
M.H*S*%:/0YKA@51.E0.%&PS7KNB+*)LM;%'J;D&B+3@(C 9SF2Y7^\9MK05"
M15L<F9\WQ01)!&+95)%[/?&__71A(),]6^7 0N@I@T$=>.!5=([QF;HV+*=$
MO=)S1=!X-(*_]S,Z9EZJ:JHCVQTXXP4P4/H@2J' M5=@VIC5&KK$?%U862]+
MVTV_I+HI1-8C+&H[0PJE^ )=E,H,.L*S.$;V--9Y4>Y0_*9 #;LG9EF!P2$"
M7L3TKKUEM*@_$5/DUW("S&V9QB9 PX1.<(IL8I4FF6S],/$2TWZCLC?T/M=9
M56 .VRI/=3'I[A_F:&H1\_;!]*-MC$#!$EK,?G'OL# XL, HJW+-:2"6ERVN
MEVWL$""KIUP_PQ'4[8DOSWOI#;, ?O;R/S9Y9A3V %-<R51&$YU2= KL\;0.
MP$"&;B,X8(A;RCLM:)7*,SCG=!:ZNJ2VO>?:S5,NX=F:!7;<B_#]Q]\D?/]Q
M"-\/X?LA?/^>!W6M:<H;#.I*=_HCN)0Y%GAL5'S0DT)HUR;K*8_6-[2KSFI6
M%V2-/J;9-5?-IM!=E.^E=AD1ZP(45+C1)(.C3&<FLV)=R69"(B/E8*M3*F+.
MIX[H7?'65GE8,2Y\TE8)K^T95%O"EHH@9RD,=?"),GV+U[4F! H7!A-3FQ@B
M/M5&%*9\DH6K:H%J&EQA&H?8<U5B*8&5\[/.C)^5;URA31&ZFQ<(TV"IE$*Z
MB?C4ITC-*(%_G0S6S8.+WX7@YOM\#ZYGSE88^2&J:61X!%H8IA2C'VK&;?HM
M^'A-;\%+/V2YOF/PVM#UV<92[?G'5ETIX-V-FDN(O\FUPAKHK3)*O)U8B\[=
M;:UW406[H3X3-%UR9I(&P75T@A<</'$M<Y-O$6V'9")4=>%2D_DEGV6%ZBHK
M0\69<V7,D*:F$UU+G,.%336QHCH 5%O9/5SAU>?J1=W<#R=H1",;OH\I4+@-
M3&Z>9 4O-U?3BO1,X\C(<M1C.^$5>4HP;_-TEF0+E 16US# S"I&;F_9H7KV
M+C8B"QP35Q.LHW.!^'=5(/, "8+RL2AZP?8$MSAU J^3P4[[.Q;8X]>$5'P?
M+,:RQ_5DD->R<!EY.%=4##UB(I]FS75#M%6N0L&/C3[FZPF42R260!ZI"%/%
M88:K5H(T<^C+29Y55S#XK?XV-+]4T-6\Y.X,OJK<!=4SMU8/KX9(%466TPTF
MX>VKE%.L;+VFEDVN.[@!)55"CTU--_*:8*FW1BZLR!/*=>TG-$2)#D!V3072
MW&327$^'.MY B;P>5^BEKF5#<\0Q9QW5$&A*:4MT,Y%S"X9ANPV\;QL#(@V4
ML=&4L9Y>":KZF<!%$2\$FFU3JS"M((J5(ILI7(&J#0*Y)J:I6KE1<U;W IEL
M-)FLI]&259A8S13M(MXB:JZ2;%9;&%80C&]/J$J=Z'\WRD-Y5@0'>)PY4XWS
M$Z!4YUD!7D)/@8PVF8R>K"49::]F.Y"-*<-49QMN6^]ZM4.K4<*]4S,QKCK"
M$!+PL65[L]8U!J9Q*:D81H,YO[,9HBRKU"@^V>@W(, :,(?'EJR1WGW''DJ<
MCBK*AO8D2DPD'IQN]]+IMIZ$!R/_12((-2!--MK']F1-3<A4&<PF?1][3K"2
M2_&A.@+<V, CZ#NZ.5P=AN5J#_CX)T1B%_P\J_2VEN!B.:M^F5<.5R_%-9&3
MR]GO]U9_VRI0R.41G/G GP@ENY?CDN'@=AYDOR/</?3E3:G7'FVX:#:8I-?3
M7(XD71.1%,4,)+6QCJS9&@F"B[K8&IA46J.BF 9R#Y.!SDIU-JP-1@H=U6H9
M=N%$1'87U_$8Q@#(/;JG=L4%U?Z@N=@QUNR >($NJ[+)!NKP'&XND.2]D_V>
MKB6AP<@'H)?D/C"?@)&8HPL3\J5Q*"^Q\=?(TS66#"WZRL07PM5 %P=53F(]
MWX?^ZL(K-83<',')'/NFF$ZDHY.1*J^Q6I-?EH(+)2F\KQSBIZC88C"59<G7
M04O@Y"!I PMC7%&N<+0V$KN@:EE4Z\H4L7*C0*,)VD?0]Y1QPZW^*$YOA .=
MJOR*<%;V26^JM!((LYI4V (&;BJ+%<Y,T:6E4% LD]68B;F-Y93K\2[?Q%Z/
MS:N8BV)SO:A_J[BQ '-&=XW@!FV'D >>M+D\:7U%VPY$J&8A$9W)/0IB(#)W
M2ET'UW#!!V.,+Q0ZH;R:IG0]FAP3A%(:/,="S&$D,7&T/ /%$OA%(J^Y6AS]
M9*JTL5D4P2CXB*>Y-E1>5\F.5--14#$WF0[7$_8QY(N;ZA[27T0^ME:A;R/J
MH#WX,"*D5LFW*=GYJ="@BF15<$5!T"4C;<L/2HKH+QE,9=W>OU6Y+F*N6FF[
MC4R!1$RN0%[SMK" A>IA1?BD6!M1#_MH.3&\1/4]NIDQ5K]0!KUL)P?]N-%G
MK$^##@SC$[HT,@_<S$5&*0 R+A!I8&)T;]LYHEE+$H>!::X7/[@70?5/ODE0
M_9,05!^"ZD-0_3VW;3U;RQL>1OY62:K $<Q7FRRB/EMC\]7$G& 7[V;2UX%"
MIDK\LIPLQW.3)8=CZ;Q(.=#]0-C5RE2\]LU6J,6!<(=&H(:>1^%V&(P#@BE<
MV@QJ,4%Z^/Y42=(3,XYAST'X*!L0MJ(:4>)Q1-PD,KVJ4&H(Q;7O_Y7Q?"TI
M#D;>IU@99Q,]G,"II51WAVPZ"5?))E\ES]?T*NE*P%+4[H^"C9 .<8)6 %L1
ML<M;@5<$XU=Z(J[8E@E?^WE;G8N^UPJED75P&O23PH7@FD5 ,_LRR$XIHY+Q
M,J3LR,*Z%QQ,E"$ =)'EB/(Y-&^Q>0+Z"Q?+!E/J>OH''*7B8>? 3:9 U?;3
MV[2O8PH"-7 RC^RJF<FYVDQ58)UL3DZK;8CL.$A-@F1GXRMDHFR29B+@*4:S
M(I@9@=&>[1*E/1UKF2^ +6@+1X-71E6A4TRDBBAJ?+HV3%Y/% -C%NR?A(&[
M_@J0<8OZ,]4+J],F85*CW3I?AJ;@"$K-A(F7\FQJEL_X1G& N(9HX;5\!AN[
M A'VWP@GAW91VOZ] J&8$$":!S^5O\%Z86H&XSSAS+39-;HOMV+8%!*S,\ZK
MRI^VR>:;V@Y1A";^=VBLNYC?31<?=P6F\Y6UR#&5L;HAS<3*O</9IQ7L#[+1
M>:9C;V&F<+9,NMZK+,/##P_AHK!O"%Y"?Q-S<)ABK,MN8"0[BU*@ 1ZP;9J]
M6%XR8(9!CL@MM>0S[C43;UUK2DX^FNIR":[E9DEX2;^:2",)6+U\NW@/\ ^R
MN:X.ET7)BBDYROZ3EU%FH%YXU4D^]?6=<IA-*5^RPMS%QUFND!2'H$,5)3L!
MF+H^I'3@+F"XP"*V&GE7#H?'PP\7K4PJVR*O$N0=;A%8YS*K0'A3>\.A*7]L
MDCF3_9U;#/?:!M]KZ^EO:QUV.MB+9C8^9) >&S&7RI(&1GP+/@)C5\!;MY[O
M;=<73"P7A6,92Z\"ORV0_Y5LUG"E /9VG_0<AARH;-7HR*W7-2"4AU51)<05
M<-TQ%B\BQJI3SR(2K![WV>IQL+>6I DC/]+%K"J-&O<&KT42FT[D=;"=;_)U
M R=Z/0T>EQU"IXNNX6,.O'VD$TW6BY8]?!G&N60"09VKB;3LU9"L*Z*@&MV8
M !W9/DA0Q ^V E;/"?RY&H,\FD:NF /(N6FD9PF/T(*ZZ ,U2?"K;,QJ1,PT
M+&"U*/ 56X0'"4W:@H@VE,CEF9#Y'W2O,JFG8)?&V6"*+)E[&$_V,%1Y>=-$
ML;=QN[,&"D9]T@7J?*;%IG ]5C%5+^5^3/F(N4HK985QTJ](O3(UT+;,#Y$L
MC Z)@Z(&M@U6COK9O=@5P 39M7%(4!WK-W%?>U-9:K<QM.U=,< PE0XO"Z6]
MH%R!A=WD-@J(1!>[E#@'75H?C-%1=#J'Q>>Z*PM^WFQ^=\>LH9D,B%1DA'Q
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MC Q]![4K%Q9HA@*R+20H9I,,4U&7A#>+LIG)7U&/W&Z$\SG(F,H)&7>(+;U
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M/[YO2W5X9,L)>JUB5TOMY[9\K.Y7UPI]J<9<-V-=V#D]]':^H$?]<(K'4^F
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MT22T>*@.$!D,X4 F]; ';\B)1/'8=OLPV[]1!]R8YM4P'-T*VGVTC]#)(W7
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MH@!3E9-8<<EP*\MOWK,8B3R1I1(\+4+]"G:P0-T*HD;0C&JK+/'WB4,\YHS
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MO+!Q$@]BZV;]$\G^/U7\\A]02P,$%     @ KC5"6>1QV$YS!   ?2T  !4
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M8^>8>9*6UNP V>G@25YJL>MTL>,07TF"#?_X="Y1/^J?O7CG7U!+ P04
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M.3 T-RYH=&U02P$"% ,4    " "N-4)9:S]V@V4#  !N#0  $0
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LG@  ;&]D93(P,C0Q,# Q7SAK+FAT;5!+!08     !P ' +\!  #OL      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>lode20241001_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lode-20241001.xsd" xlink:type="simple"/>
    <context id="d20248K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001120970</identifier>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-01</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20248K" id="ixv-240">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20248K" id="ixv-241">0001120970</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20248K" id="ixv-16">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20248K" id="ixv-251">2024-10-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20248K" id="ixv-27">COMSTOCK INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20248K" id="ixv-36">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20248K" id="ixv-42">001-35200</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20248K" id="ixv-47">65-0955118</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20248K" id="ixv-54">117 American Flat Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20248K" id="ixv-56">Virginia City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20248K" id="ixv-58">NV</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20248K" id="ixv-60">89440</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20248K" id="ixv-65">775</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20248K" id="ixv-67">847-5272</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20248K" id="ixv-252">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20248K" id="ixv-253">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20248K" id="ixv-254">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20248K" id="ixv-255">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="d20248K" id="ixv-256">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20248K" id="ixv-257">LODE</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20248K" id="ixv-258">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="d20248K" id="ixv-259">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
